candidate_genes,disease,celltype,y,user_question,full_query
"['CNGA1', 'CALR3', 'PARP4', 'TBC1D25', 'HDAC2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,HDAC2,"Which gene—CNGA1, CALR3, PARP4, TBC1D25, or HDAC2—exhibits the highest cell-type specificity for CD4-positive alpha-beta cytotoxic T lymphocytes, making it the most promising target for follicular lymphoma therapy?","Which gene—CNGA1, CALR3, PARP4, TBC1D25, or HDAC2—exhibits the highest cell-type specificity for CD4-positive alpha-beta cytotoxic T lymphocytes, making it the most promising target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific gene embeddings from the PINNACLE database. Next, determine the intersection between these targets and the set of activated genes from CD4-positive alpha-beta cytotoxic T cells in PINNACLE. Calculate the mean embedding for the overlapping set, then compute the cosine similarity between this averaged embedding and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC7', 'KRTAP5-1', 'RETREG2', 'ST8SIA3', 'BCOR']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,HDAC7,"Among HDAC7, KRTAP5-1, RETREG2, ST8SIA3, and BCOR, which gene shows the highest cell-type specificity in CD4-positive αβ cytotoxic T cells as a potential target for follicular lymphoma?","Among HDAC7, KRTAP5-1, RETREG2, ST8SIA3, and BCOR, which gene shows the highest cell-type specificity in CD4-positive αβ cytotoxic T cells as a potential target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in CD4-positive alpha-beta cytotoxic T cells in PINNACLE, considering this overlapping set as the follicular lymphoma cell-type–specific targets. Calculate the average embedding of these genes as a reference, then compute the cosine similarity between this reference and each target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MLH3', 'ECH1', 'FKBP2', 'NDUFS6', 'PSMB2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFS6,"Which gene among MLH3, ECH1, FKBP2, NDUFS6, and PSMB2 displays the highest cell-type specificity within CD4-positive, alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among MLH3, ECH1, FKBP2, NDUFS6, and PSMB2 displays the highest cell-type specificity within CD4-positive, alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the CD4-positive, alpha-beta cytotoxic T cell activation genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set, and then compute the cosine similarity between this average embedding and the embeddings of each individual target gene. Finally, if one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SEC11A', 'TOP2B', 'STAG1', 'CTDSPL', 'PRF1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TOP2B,"Among SEC11A, TOP2B, STAG1, CTDSPL, and PRF1, which gene exhibits the greatest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among SEC11A, TOP2B, STAG1, CTDSPL, and PRF1, which gene exhibits the greatest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which genes associated with activated CD4-positive αβ cytotoxic T cells overlap with these targets. Calculate the average embedding for the overlapping genes and then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM9', 'NACA4P', 'ZNF649', 'CDK4', 'PIWIL1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,CDK4,"Among the genes TMEM9, NACA4P, ZNF649, CDK4, and PIWIL1, which one exhibits the highest cell-type specificity in CD4-positive αβ T cells for potential targeting of follicular lymphoma?","Among the genes TMEM9, NACA4P, ZNF649, CDK4, and PIWIL1, which one exhibits the highest cell-type specificity in CD4-positive αβ T cells for potential targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the CD4-positive alpha-beta cytotoxic T cell–activated genes in PINNACLE overlap with these targets. Calculate the average embedding of this overlapping gene set, then compute the cosine similarity between this reference and each individual gene embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BLVRA', 'CDK11B', 'STK3', 'LCK', 'CBLIF']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,LCK,"Among the genes BLVRA, CDK11B, STK3, LCK, and CBLIF, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among the genes BLVRA, CDK11B, STK3, LCK, and CBLIF, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with genes expressed in activated cd4-positive alpha-beta cytotoxic T cells. Using the overlapping gene set, compute a reference average embedding and calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its relevance to follicular lymphoma."
"['MDM2', 'RPS6KA1', 'C2orf83', 'PTPRR', 'TMEM167A']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,MDM2,"Among the genes MDM2, RPS6KA1, C2orf83, PTPRR, and TMEM167A, which displays the highest cell-type specificity in CD4-positive αβ cytotoxic T cells in the context of targeting follicular lymphoma?","Among the genes MDM2, RPS6KA1, C2orf83, PTPRR, and TMEM167A, which displays the highest cell-type specificity in CD4-positive αβ cytotoxic T cells in the context of targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes from the PINNACLE dataset associated with activated CD4-positive alpha-beta cytotoxic T cells overlap with these targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target embedding. Finally, identify the gene with a markedly higher similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA8', 'PPP2R3C', 'HCLS1', 'ATOH1', 'CD151']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFA8,"Which gene among NDUFA8, PPP2R3C, HCLS1, ATOH1, and CD151 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene among NDUFA8, PPP2R3C, HCLS1, ATOH1, and CD151 exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in CD4-positive, alpha-beta cytotoxic T cells to define the cell-type–specific target set for follicular lymphoma. Compute the average embedding for this set, then calculate the cosine similarity between the average and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NRBP1', 'LEPR', 'TUBB4B', 'TSSK1B', 'VPREB3']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TUBB4B,"Which gene—NRBP1, LEPR, TUBB4B, TSSK1B, or VPREB3—exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene—NRBP1, LEPR, TUBB4B, TSSK1B, or VPREB3—exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta cytotoxic T cell-activated genes available in PINNACLE. Compute the average embedding for the overlapping genes, then calculate the cosine similarity between this averaged embedding and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ANKHD1', 'RAD54B', 'CMC2', 'PTH', 'NDUFA12']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFA12,"Which gene among ANKHD1, RAD54B, CMC2, PTH, and NDUFA12 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Which gene among ANKHD1, RAD54B, CMC2, PTH, and NDUFA12 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the CD4-positive alpha-beta cytotoxic T cell activation gene set in PINNACLE. For the overlapping genes, compute the average embedding as a reference profile and calculate the cosine similarity between each gene’s embedding and this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IL6R', 'CDKN2D', 'SYT16', 'NR2C2AP', 'KRTAP3-2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,IL6R,"Among the genes IL6R, CDKN2D, SYT16, NR2C2AP, and KRTAP3-2, which one exhibits the highest specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among the genes IL6R, CDKN2D, SYT16, NR2C2AP, and KRTAP3-2, which one exhibits the highest specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, compare these targets with the CD4-positive alpha-beta cytotoxic T cell activated genes from PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and determine the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TNFRSF4', 'TBC1D8', 'DDX19A', 'SLC37A1', 'LAMC1']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,TNFRSF4,"Which gene among TNFRSF4, TBC1D8, DDX19A, SLC37A1, and LAMC1 exhibits the highest cell-type specificity for CD4-positive alpha-beta cytotoxic T cells in the context of follicular lymphoma targeting?","Which gene among TNFRSF4, TBC1D8, DDX19A, SLC37A1, and LAMC1 exhibits the highest cell-type specificity for CD4-positive alpha-beta cytotoxic T cells in the context of follicular lymphoma targeting? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes associated with activated cd4-positive alpha-beta cytotoxic T cells in PINNACLE. Calculate the average embedding of the overlapping set to serve as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PTGES', 'NDUFB9', 'ELOVL5', 'XPO6', 'MAD2L2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB9,"Which gene among PTGES, NDUFB9, ELOVL5, XPO6, and MAD2L2 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells, making it the best candidate for targeting follicular lymphoma?","Which gene among PTGES, NDUFB9, ELOVL5, XPO6, and MAD2L2 exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells, making it the best candidate for targeting follicular lymphoma? Identify all verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta cytotoxic T cell–activated genes within PINNACLE. For the overlapping set, compute the average embedding and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate, providing a concise rationale that supports its biological relevance."
"['NDUFB10', 'TCP11', 'DDX31', 'SH3BP5L', 'UST']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB10,"Among the genes NDUFB10, TCP11, DDX31, SH3BP5L, and UST, which exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among the genes NDUFB10, TCP11, DDX31, SH3BP5L, and UST, which exhibits the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the CD4-positive alpha-beta cytotoxic T cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS8', 'TNKS2', 'RPS28', 'MAGEA3', 'CTCF']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFS8,"Which gene among NDUFS8, TNKS2, RPS28, MAGEA3, and CTCF exhibits the most cell-type specific expression in CD4-positive αβ cytotoxic T cells, thereby serving as the optimal candidate for targeted follicular lymphoma therapy?","Which gene among NDUFS8, TNKS2, RPS28, MAGEA3, and CTCF exhibits the most cell-type specific expression in CD4-positive αβ cytotoxic T cells, thereby serving as the optimal candidate for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, compare these targets with the set of cd4-positive alpha-beta cytotoxic T cell–activated genes in PINNACLE to determine the overlapping genes, which represent the cell-type–specific targets. Compute the average embedding of this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KIF14', 'NDUFB2', 'RFLNA', 'PES1', 'ZNF490']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFB2,"Among the candidate genes KIF14, NDUFB2, RFLNA, PES1, and ZNF490, which one demonstrates the highest specificity in CD4-positive alpha-beta cytotoxic T cells for potential targeting of follicular lymphoma?","Among the candidate genes KIF14, NDUFB2, RFLNA, PES1, and ZNF490, which one demonstrates the highest specificity in CD4-positive alpha-beta cytotoxic T cells for potential targeting of follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. From PINNACLE, determine the intersection with CD4-positive, alpha-beta cytotoxic T cell-activated genes to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference and calculate the cosine similarity between the reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['IMPDH1', 'AKR7A3', 'MT1JP', 'FLG', 'CGN']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,IMPDH1,"Which gene among IMPDH1, AKR7A3, MT1JP, FLG, and CGN demonstrates the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeted therapy against follicular lymphoma?","Which gene among IMPDH1, AKR7A3, MT1JP, FLG, and CGN demonstrates the highest cell-type specificity in CD4-positive alpha-beta cytotoxic T cells for targeted therapy against follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of CD4-positive, alpha-beta cytotoxic T cell-activated genes within PINNACLE, establishing the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this reference embedding and the individual embeddings of each target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate, and provide a brief, evidence-based rationale for its biological relevance."
"['COMMD8', 'PCGF5', 'NDUFC2', 'PPP1R15B', 'RBM8A']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFC2,"Among the genes COMMD8, PCGF5, NDUFC2, PPP1R15B, and RBM8A, which one shows the highest specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma?","Among the genes COMMD8, PCGF5, NDUFC2, PPP1R15B, and RBM8A, which one shows the highest specificity in CD4-positive alpha-beta cytotoxic T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type specific embeddings from PINNACLE. Next, determine which of the CD4-positive, alpha-beta cytotoxic T cell-associated genes in PINNACLE overlap with these targets to define cell-type specific candidates for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FMNL1', 'BCL2A1', 'NQO1', 'CSRP2', 'MAVS']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,BCL2A1,"Among the genes FMNL1, BCL2A1, NQO1, CSRP2, and MAVS, which one shows the highest expression specificity within CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes FMNL1, BCL2A1, NQO1, CSRP2, and MAVS, which one shows the highest expression specificity within CD4-positive alpha-beta cytotoxic T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the cd4-positive alpha-beta cytotoxic T cell-activated genes in PINNACLE overlap with these targets. Using this overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DENND1C', 'NDUFV2', 'CDPF1', 'THAP7', 'HLA-DQA2']",follicular lymphoma,cd4-positive alpha-beta cytotoxic t cell,NDUFV2,"Which gene among DENND1C, NDUFV2, CDPF1, THAP7, and HLA-DQA2 exhibits the highest specificity in CD4-positive alpha-beta cytotoxic T cells for the targeting of follicular lymphoma?","Which gene among DENND1C, NDUFV2, CDPF1, THAP7, and HLA-DQA2 exhibits the highest specificity in CD4-positive alpha-beta cytotoxic T cells for the targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta cytotoxic T cell–activated gene set in PINNACLE. For the overlapping genes, compute an average embedding to serve as a reference vector, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-supported explanation for its biological relevance."
"['KIDINS220', 'NR4A1', 'ZSCAN4', 'NDUFS7', 'RNF166']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS7,"Which gene, among KIDINS220, NR4A1, ZSCAN4, NDUFS7, and RNF166, exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene, among KIDINS220, NR4A1, ZSCAN4, NDUFS7, and RNF166, exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which naive thymus-derived CD4-positive αβ T cell activation genes from PINNACLE overlap with these targets to define a subset of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this subset as a reference and evaluate the cosine similarity between this reference and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['QARS1', 'RMRP', 'NDUFB3', 'SPIRE1', 'HEXIM2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFB3,"Which gene among QARS1, RMRP, NDUFB3, SPIRE1, and HEXIM2 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for targeted follicular lymphoma therapy?","Which gene among QARS1, RMRP, NDUFB3, SPIRE1, and HEXIM2 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of genes associated with activated, naive thymus-derived CD4-positive alpha-beta T cells in PINNACLE. Compute the average embedding for this overlapping set as a reference, and then calculate the cosine similarity between the reference embedding and each individual target's embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS5', 'EIPR1', 'DAD1', 'CXorf66', 'ZNF335']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS5,"Which of the following genes—NDUFS5, EIPR1, DAD1, CXorf66, or ZNF335—exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the best candidate for targeting follicular lymphoma?","Which of the following genes—NDUFS5, EIPR1, DAD1, CXorf66, or ZNF335—exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells, making it the best candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in naive, thymus-derived CD4-positive αβ T cells as represented in PINNACLE. Calculate the average embedding for this overlapping gene set, then compute the cosine similarity between this reference embedding and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LPP', 'BCL2', 'PPWD1', 'ZNF513', 'COG7']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,BCL2,"Among the genes LPP, BCL2, PPWD1, ZNF513, and COG7, which one shows the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells for potential targeting of follicular lymphoma?","Among the genes LPP, BCL2, PPWD1, ZNF513, and COG7, which one shows the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells for potential targeting of follicular lymphoma? Using the PINNACLE resource, identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings. Next, determine the overlap with the naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE. Calculate the average embedding for the overlapping set, then compute the cosine similarity between this average and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['POLD4', 'EDN3', 'RNU1-1', 'PAFAH1B3', 'ASH2L']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,POLD4,"Among POLD4, EDN3, RNU1-1, PAFAH1B3, and ASH2L, which gene exhibits the highest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma?","Among POLD4, EDN3, RNU1-1, PAFAH1B3, and ASH2L, which gene exhibits the highest cell-type specificity in naive, thymus-derived CD4+ alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic target genes for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, from the set of naive thymus-derived, CD4-positive, alpha-beta T cell activation genes in PINNACLE, determine the overlap with these targets—this overlapping gene set represents the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for these overlapping targets and then compute the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DNTTIP2', 'ALDH5A1', 'RAB3D', 'NDUFA12', 'MAN1C1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFA12,"Among the genes DNTTIP2, ALDH5A1, RAB3D, NDUFA12, and MAN1C1, which one shows the highest specificity in naive, thymus-derived CD4-positive αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Among the genes DNTTIP2, ALDH5A1, RAB3D, NDUFA12, and MAN1C1, which one shows the highest specificity in naive, thymus-derived CD4-positive αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the naive thymus-derived CD4-positive αβ T cell-activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for the overlapping set to use as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['GJB6', 'CELF2', 'AHR', 'ARHGEF5', 'CCNK']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,CELF2,"Among the genes GJB6, CELF2, AHR, ARHGEF5, and CCNK, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells for targeting follicular lymphoma?","Among the genes GJB6, CELF2, AHR, ARHGEF5, and CCNK, which one exhibits the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the set of naive thymus-derived, CD4-positive, alpha-beta T cell-activated genes in PINNACLE to establish the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping gene set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SECISBP2', 'SMIM2', 'NDUFAF2', 'ZNF235', 'NCAPG2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFAF2,"Among SECISBP2, SMIM2, NDUFAF2, ZNF235, and NCAPG2, which gene shows the highest specificity of expression in naive thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Among SECISBP2, SMIM2, NDUFAF2, ZNF235, and NCAPG2, which gene shows the highest specificity of expression in naive thymus-derived CD4+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embedding profiles from PINNACLE. Next, determine which of these targets overlap with the set of naive thymus–derived CD4-positive alpha-beta T cell–activated genes available in PINNACLE. For the overlapping genes, calculate the average embedding as a reference, then compute the cosine similarity between this reference and each individual gene embedding. If a single gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate gene and provide a concise, evidence-based explanation for its biological significance."
"['PTPRB', 'GPBP1L1', 'IFNAR2', 'ACTL6A', 'KCTD21']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,IFNAR2,"Which gene among PTPRB, GPBP1L1, IFNAR2, ACTL6A, and KCTD21 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for targeted therapy in follicular lymphoma?","Which gene among PTPRB, GPBP1L1, IFNAR2, ACTL6A, and KCTD21 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine which genes associated with naive thymus-derived CD4-positive alpha-beta T cell activation overlap with these targets, thereby defining the cell-type-specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes to establish a reference profile, and then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LDLRAD1', 'RNF125', 'JADE1', 'NDUFB6', 'LEUTX']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFB6,"Which gene among LDLRAD1, RNF125, JADE1, NDUFB6, and LEUTX exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, thereby representing a promising therapeutic target for follicular lymphoma?","Which gene among LDLRAD1, RNF125, JADE1, NDUFB6, and LEUTX exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells, thereby representing a promising therapeutic target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma in PINNACLE and extract their cell-type–specific embeddings. Next, determine which of these overlap with the naive thymus-derived CD4-positive alpha–beta T cell–activated genes from PINNACLE, as this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these genes, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C2CD5', 'LYSMD2', 'DOC2B', 'C4orf45', 'PIK3R1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,PIK3R1,"Among the genes C2CD5, LYSMD2, DOC2B, C4orf45, and PIK3R1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for application in targeting follicular lymphoma?","Among the genes C2CD5, LYSMD2, DOC2B, C4orf45, and PIK3R1, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells for application in targeting follicular lymphoma? Identify confirmed therapeutic targets for follicular lymphoma and obtain their cell-type specific embeddings from PINNACLE. Next, determine which of the naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type specific targets for follicular lymphoma. Compute the average embedding of this set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM204', 'AVPR1A', 'CS', 'HACD2', 'PPIA']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,PPIA,"Among the genes TMEM204, AVPR1A, CS, HACD2, and PPIA, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma?","Among the genes TMEM204, AVPR1A, CS, HACD2, and PPIA, which one exhibits the highest cell-type specificity in naive thymus-derived CD4+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets, defining this intersection as the cell-type-specific targets for follicular lymphoma. Compute the average embedding for this set, then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FKBP1A', 'MCUB', 'RHBDF1', 'MSS51', 'SPAG5']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,FKBP1A,"Among the candidate genes FKBP1A, MCUB, RHBDF1, MSS51, and SPAG5, which one demonstrates the highest cell-type specific expression in naive thymus-derived CD4-positive alpha-beta T cells, thereby representing the most promising therapeutic target for follicular lymphoma?","Among the candidate genes FKBP1A, MCUB, RHBDF1, MSS51, and SPAG5, which one demonstrates the highest cell-type specific expression in naive thymus-derived CD4-positive alpha-beta T cells, thereby representing the most promising therapeutic target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, isolate the set of naive thymus-derived CD4-positive alpha-beta T cell–activated genes within PINNACLE, and determine which genes from this set overlap with the verified targets—this overlapping set comprises the cell-type–specific targets for follicular lymphoma. Compute the average embedding of these targets and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['KLHL12', 'TUBB', 'ODR4', 'TTC21B', 'TREM2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,TUBB,"Which gene—KLHL12, TUBB, ODR4, TTC21B, or TREM2—exhibits the highest specificity in naive thymus-derived CD4-positive αβ T cells, making it the most promising target for follicular lymphoma therapy?","Which gene—KLHL12, TUBB, ODR4, TTC21B, or TREM2—exhibits the highest specificity in naive thymus-derived CD4-positive αβ T cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, among the naive thymus–derived CD4+ αβ T cell–activated genes in PINNACLE, determine which ones overlap with these therapeutic targets. Calculate the average embedding of this overlapping set to use as a reference and compute the cosine similarity between this reference and each individual gene’s embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['NDUFS3', 'RBBP8', 'FBXL3', 'CATSPER4', 'CTDNEP1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFS3,"Which gene—NDUFS3, RBBP8, FBXL3, CATSPER4, or CTDNEP1—demonstrates the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene—NDUFS3, RBBP8, FBXL3, CATSPER4, or CTDNEP1—demonstrates the highest cell-type specificity in naive thymus-derived CD4-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the naive thymus-derived CD4-positive, alpha-beta T cell-activated genes in PINNACLE overlap with these targets, forming the cell-type–specific target set for this lymphoma. Compute the average embedding for this overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PARP2', 'ELK4', 'DMTN', 'PAEP', 'NDUFB9']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFB9,"Which gene—PARP2, ELK4, DMTN, PAEP, or NDUFB9—demonstrates the highest specificity in naïve thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene—PARP2, ELK4, DMTN, PAEP, or NDUFB9—demonstrates the highest specificity in naïve thymus-derived CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma from the PINNACLE dataset and extract their cell-type–specific embeddings. Next, find the overlap between these targets and the naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE, as this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping group and then calculate the cosine similarity between this average and each individual target embedding. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a brief evidence-based rationale for its biological relevance."
"['ARHGAP5', 'SRSF9', 'NDUFA8', 'WNT5A', 'MATN2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,NDUFA8,"Which gene among ARHGAP5, SRSF9, NDUFA8, WNT5A, and MATN2 demonstrates the highest specificity in naive thymus-derived CD4-positive αβ T cells, thereby representing the best candidate for targeting follicular lymphoma?","Which gene among ARHGAP5, SRSF9, NDUFA8, WNT5A, and MATN2 demonstrates the highest specificity in naive thymus-derived CD4-positive αβ T cells, thereby representing the best candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embedding data from the PINNACLE database. Next, determine the overlap between these targets and the naive thymus-derived CD4-positive αβ T cell activation gene set provided by PINNACLE. Using the overlapping genes as the cell-type–specific targets for follicular lymphoma, compute their average embedding and then calculate the cosine similarity between this averaged embedding and the embedding of each individual target. If one gene shows a markedly higher similarity than the others, nominate that gene as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LCK', 'UBE2W', 'ACAP3', 'ARPC1A', 'ANKLE2']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,LCK,"Among the candidate genes LCK, UBE2W, ACAP3, ARPC1A, and ANKLE2, which one displays the highest specificity for naive thymus-derived CD4-positive αβ T cells, making it the most promising target for follicular lymphoma?","Among the candidate genes LCK, UBE2W, ACAP3, ARPC1A, and ANKLE2, which one displays the highest specificity for naive thymus-derived CD4-positive αβ T cells, making it the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma in PINNACLE and extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the naive thymus-derived CD4-positive alpha-beta T cell–activated genes in PINNACLE. Calculate the average embedding for this overlapping gene set and then compute the cosine similarity between this average and each individual target gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FPGT', 'IL6R', 'MGST1', 'CCL27', 'PLPPR1']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,IL6R,"Among FPGT, IL6R, MGST1, CCL27, and PLPPR1, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells and is most promising for targeting follicular lymphoma?","Among FPGT, IL6R, MGST1, CCL27, and PLPPR1, which gene exhibits the highest cell-type specificity in naive thymus-derived CD4+ alpha-beta T cells and is most promising for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma within PINNACLE and retrieve their cell-type–specific embeddings. Next, intersect these targets with the naive, thymus-derived CD4-positive alpha-beta T cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['E2F6', 'CCKBR', 'IMPDH1', 'CLCA4', 'GET3']",follicular lymphoma,naive thymus-derived cd4-positive alpha-beta t cell,IMPDH1,"Which gene among E2F6, CCKBR, IMPDH1, CLCA4, and GET3 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for potential targeting of follicular lymphoma?","Which gene among E2F6, CCKBR, IMPDH1, CLCA4, and GET3 exhibits the highest cell-type specificity in naive thymus-derived CD4-positive alpha-beta T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive thymus-derived CD4-positive alpha-beta T cell-activated genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping gene set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['NDUFA4', 'KRTAP22-1', 'ACVR1', 'B3GNT2', 'SMOC1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFA4,"Which gene among NDUFA4, KRTAP22-1, ACVR1, B3GNT2, and SMOC1 exhibits the highest specificity of expression in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among NDUFA4, KRTAP22-1, ACVR1, B3GNT2, and SMOC1 exhibits the highest specificity of expression in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma using the PINNACLE database and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and genes linked to naive, thymus-derived, CD8-positive, alpha-beta T cell activation in PINNACLE. Calculate the average embedding of the overlapping genes and compute the cosine similarity between this reference and each individual target. If one gene exhibits substantially higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological significance."
"['CRYBB1', 'GFUS', 'WASH8P', 'IL2RB', 'TLK1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,IL2RB,"Among CRYBB1, GFUS, WASH8P, IL2RB, and TLK1, which gene exhibits the highest cell-type specific expression in naive thymus-derived CD8-positive alpha-beta T cells, making it the most promising target for follicular lymphoma therapy?","Among CRYBB1, GFUS, WASH8P, IL2RB, and TLK1, which gene exhibits the highest cell-type specific expression in naive thymus-derived CD8-positive alpha-beta T cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma from PINNACLE and retrieve their cell-type–specific embeddings. Next, determine which of these targets overlap with the embeddings of naive, thymus-derived, CD8-positive alpha-beta T cells (using their activated gene profiles). Calculate the average embedding for the overlapping set, then compute the cosine similarity between this reference vector and each individual target’s embedding. If one gene consistently shows markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCL24', 'DCX', 'MYL7', 'NDUFS7', 'GNA11']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS7,"Which gene among CCL24, DCX, MYL7, NDUFS7, and GNA11 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting of follicular lymphoma?","Which gene among CCL24, DCX, MYL7, NDUFS7, and GNA11 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting of follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell‐type–specific embeddings from the PINNACLE database. Among the naive thymus-derived CD8-positive αβ T cell activation genes in PINNACLE, determine which ones overlap with these targets. Calculate the average embedding for the overlapping genes, then compute the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['PKD1L2', 'TNNT1', 'RNPS1', 'AREL1', 'HSP90AA1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AA1,"Among the genes PKD1L2, TNNT1, RNPS1, AREL1, and HSP90AA1, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Among the genes PKD1L2, TNNT1, RNPS1, AREL1, and HSP90AA1, which exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, from the set of PINNACLE genes associated with naive thymus-derived CD8-positive αβ T cell activation, determine which overlap with these targets. Compute the average embedding for the overlapping set as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ISOC2', 'CXCL13', 'RPL32', 'ACACB', 'NDUFV2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFV2,"Among the candidate genes ISOC2, CXCL13, RPL32, ACACB, and NDUFV2, which shows the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Among the candidate genes ISOC2, CXCL13, RPL32, ACACB, and NDUFV2, which shows the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the naive, thymus-derived, CD8-positive, alpha-beta T cell activation genes within PINNACLE to define the specific target set for follicular lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['HSP90AB1', 'PKD2L1', 'GABPB1', 'TNFRSF14', 'DCBLD2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,HSP90AB1,"Which gene among HSP90AB1, PKD2L1, GABPB1, TNFRSF14, and DCBLD2 exhibits the highest specificity for naive thymus-derived CD8+ αβ T cells in the context of follicular lymphoma targeting?","Which gene among HSP90AB1, PKD2L1, GABPB1, TNFRSF14, and DCBLD2 exhibits the highest specificity for naive thymus-derived CD8+ αβ T cells in the context of follicular lymphoma targeting? Which verified therapeutic targets for follicular lymphoma, as defined in PINNACLE, have cell-type–specific embeddings? Among these, which targets overlap with the set of naive thymus-derived CD8-positive alpha-beta T cell–activated genes in PINNACLE? Using this overlapping set as the cell-type–specific targets for follicular lymphoma, compute their average embedding and then determine the cosine similarity between this average and the embedding for each individual target. If one target exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['TCF7L1', 'PPIA', 'LYG2', 'SLC32A1', 'LAMC2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,PPIA,"Which gene among TCF7L1, PPIA, LYG2, SLC32A1, and LAMC2 exhibits the highest cell-type specificity in naive thymus-derived CD8-positive αβ T cells for potential targeting of follicular lymphoma?","Which gene among TCF7L1, PPIA, LYG2, SLC32A1, and LAMC2 exhibits the highest cell-type specificity in naive thymus-derived CD8-positive αβ T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Then, determine which naive thymus-derived CD8-positive αβ T cell activation genes in PINNACLE overlap with these targets to obtain a subset specific to follicular lymphoma. Compute the average embedding of this subset as a reference, and calculate the cosine similarity between this reference and each individual target. Finally, if one gene demonstrates significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM97', 'ARHGDIA', 'FYN', 'ACKR4', 'ADGRB1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,FYN,"Which gene among TMEM97, ARHGDIA, FYN, ACKR4, and ADGRB1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among TMEM97, ARHGDIA, FYN, ACKR4, and ADGRB1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of naive thymus-derived, CD8-positive, αβ T cell-activated genes in PINNACLE to establish a subset of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this subset and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM100', 'CELF2', 'ACY3', 'HLA-DPB1', 'CLIC3']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,CELF2,"Which gene among TMEM100, CELF2, ACY3, HLA-DPB1, and CLIC3 exhibits the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, suggesting its potential as a target in follicular lymphoma therapy?","Which gene among TMEM100, CELF2, ACY3, HLA-DPB1, and CLIC3 exhibits the highest cell-type-specific expression in naive thymus-derived CD8+ αβ T cells, suggesting its potential as a target in follicular lymphoma therapy? Retrieve verified therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the naive thymus-derived CD8-positive alpha-beta T cell–activated genes in PINNACLE, defining the overlapping genes as the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TSSC4', 'NDUFB4', 'KRT36', 'DRD1', 'C11orf65']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB4,"Which gene, among TSSC4, NDUFB4, KRT36, DRD1, and C11orf65, exhibits the highest cell-type specificity in naive thymus-derived CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene, among TSSC4, NDUFB4, KRT36, DRD1, and C11orf65, exhibits the highest cell-type specificity in naive thymus-derived CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in naive thymus-derived CD8-positive alpha-beta T cells in PINNACLE. Compute the average embedding of the overlapping gene set, then calculate the cosine similarity between this average embedding and the embedding of each therapeutic target. If one gene shows distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KRT33A', 'SIPA1L1', 'PRR19', 'NDUFS5', 'KDM8']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFS5,"Which gene among KRT33A, SIPA1L1, PRR19, NDUFS5, and KDM8 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in follicular lymphoma?","Which gene among KRT33A, SIPA1L1, PRR19, NDUFS5, and KDM8 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for potential targeting in follicular lymphoma? Identify the therapeutic targets for follicular lymphoma documented within PINNACLE and obtain their corresponding cell-type–specific embeddings. Next, determine which of these targets overlap with the genes derived from naive thymus CD8-positive alpha-beta T cells in PINNACLE. Calculate the average embedding for this overlapping gene set and compute the cosine similarity between this average and each individual target’s embedding. Finally, nominate the gene with a significantly higher similarity as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NOD2', 'DMXL1', 'LCE1C', 'NDUFB10', 'CCK']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB10,"Among the genes NOD2, DMXL1, LCE1C, NDUFB10, and CCK, which demonstrates the highest cell-type specificity in naive thymus-derived CD8-positive alpha-beta T cells, indicating its potential as the optimal target for follicular lymphoma?","Among the genes NOD2, DMXL1, LCE1C, NDUFB10, and CCK, which demonstrates the highest cell-type specificity in naive thymus-derived CD8-positive alpha-beta T cells, indicating its potential as the optimal target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma using the PINNACLE database and retrieve their cell-type–specific embeddings. Next, determine which targets overlap with the naive thymus-derived CD8-positive alpha-beta T cell–activated gene set in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND4L', 'ROM1', 'EPHA1', 'SLC5A8', 'PFDN1']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND4L,"Which gene among MT-ND4L, ROM1, EPHA1, SLC5A8, and PFDN1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among MT-ND4L, ROM1, EPHA1, SLC5A8, and PFDN1 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the naive thymus-derived CD8-positive alpha-beta T cell activation genes in PINNACLE. For the overlapping genes, compute the average embedding vector and then calculate the cosine similarity of each individual gene to this reference. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ATG101', 'ZPR1', 'TCP10L3', 'ENPP2', 'MT-ND3']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,MT-ND3,"Among ATG101, ZPR1, TCP10L3, ENPP2, and MT-ND3, which gene shows the highest specificity within naive thymus-derived CD8-positive alpha-beta T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among ATG101, ZPR1, TCP10L3, ENPP2, and MT-ND3, which gene shows the highest specificity within naive thymus-derived CD8-positive alpha-beta T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify curated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings using PINNACLE. Then, compare these targets to the set of naive thymus–derived CD8+ alpha-beta T cell activation genes from PINNACLE to determine their overlap, which represents the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CCDC57', 'NDUFAB1', 'LSM2', 'DUT', 'MAP3K5']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFAB1,"Which gene among CCDC57, NDUFAB1, LSM2, DUT, and MAP3K5 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among CCDC57, NDUFAB1, LSM2, DUT, and MAP3K5 exhibits the highest cell-type specificity in naive thymus-derived CD8+ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the naive thymus–derived CD8-positive alpha-beta T cell activated genes in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FLII', 'PLSCR4', 'CELF2', 'SLC7A1', 'PRDM2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,CELF2,"Which gene among FLII, PLSCR4, CELF2, SLC7A1, and PRDM2 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, suggesting its potential as a target for follicular lymphoma?","Which gene among FLII, PLSCR4, CELF2, SLC7A1, and PRDM2 exhibits the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, suggesting its potential as a target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Among the genes classified as naive thymus-derived CD8+ alpha-beta T cell-activated in PINNACLE, determine which overlap with these therapeutic targets. Calculate the average embedding for this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC29A1', 'HDGFL2', 'IL2RB', 'OR7C2', 'ST6GALNAC2']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,IL2RB,"Which gene among SLC29A1, HDGFL2, IL2RB, OR7C2, and ST6GALNAC2 exhibits the most cell-type-specific expression in naive thymus-derived CD8+ alpha-beta T cells for follicular lymphoma targeting?","Which gene among SLC29A1, HDGFL2, IL2RB, OR7C2, and ST6GALNAC2 exhibits the most cell-type-specific expression in naive thymus-derived CD8+ alpha-beta T cells for follicular lymphoma targeting? Identify validated therapeutic targets for follicular lymphoma from the literature and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which targets overlap with the set of naive, thymus-derived, CD8-positive αβ T cell–activated genes available in PINNACLE. For those overlapping genes, compute the average embedding to establish a reference profile, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a notably higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SOAT2', 'SCAMP3', 'HACL1', 'ZKSCAN3', 'PPIA']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,PPIA,"Which gene—SOAT2, SCAMP3, HACL1, ZKSCAN3, or PPIA—exhibits the most specific expression in naive, thymus-derived CD8+ alpha-beta T cells, making it the best candidate for targeting follicular lymphoma?","Which gene—SOAT2, SCAMP3, HACL1, ZKSCAN3, or PPIA—exhibits the most specific expression in naive, thymus-derived CD8+ alpha-beta T cells, making it the best candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which genes representing activated naive thymus-derived CD8+ alpha-beta T cells in PINNACLE overlap with these targets. For the overlapping genes, calculate their average embedding as a reference and compute the cosine similarity between this reference and each gene’s individual embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDE6C', 'NDUFAB1', 'BPGM', 'GRM1', 'HS3ST5']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFAB1,"Among PDE6C, NDUFAB1, BPGM, GRM1, and HS3ST5, which gene shows the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the best candidate for targeting follicular lymphoma?","Among PDE6C, NDUFAB1, BPGM, GRM1, and HS3ST5, which gene shows the highest cell-type specificity in naive thymus-derived CD8+ alpha-beta T cells, making it the best candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of the naive thymus-derived CD8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping gene set and then calculate the cosine similarity between this average embedding and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate along with a concise, evidence-based rationale for its biological relevance."
"['FNDC3A', 'RNR1', 'H2AB1', 'NDUFB10', 'ACR']",follicular lymphoma,naive thymus-derived cd8-positive alpha-beta t cell,NDUFB10,"Among the genes FNDC3A, RNR1, H2AB1, NDUFB10, and ACR, which one shows the highest specificity of expression in naive thymus-derived CD8+ alpha-beta T cells, making it the best candidate for targeting follicular lymphoma?","Among the genes FNDC3A, RNR1, H2AB1, NDUFB10, and ACR, which one shows the highest specificity of expression in naive thymus-derived CD8+ alpha-beta T cells, making it the best candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes in PINNACLE associated with naive thymus-derived CD8-positive αβ T cell activation. Compute the average embedding for the overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA12', 'MFSD4B', 'OLFM4', 'BDKRB2', 'UBASH3B']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFA12,"Which gene—NDUFA12, MFSD4B, OLFM4, BDKRB2, or UBASH3B—exhibits the highest cell-type specificity in effector CD8⁺ αβ T cells for targeting follicular lymphoma?","Which gene—NDUFA12, MFSD4B, OLFM4, BDKRB2, or UBASH3B—exhibits the highest cell-type specificity in effector CD8⁺ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the set of effector CD8-positive alpha–beta T cell activation genes in PINNACLE. Compute the average embedding for the overlapping set as a reference vector, and calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLD4', 'EPRS1', 'DMRT1', 'CHRNB1', 'CDH24']",follicular lymphoma,effector cd8-positive alpha-beta t cell,POLD4,"Which gene among POLD4, EPRS1, DMRT1, CHRNB1, and CDH24 exhibits the highest specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among POLD4, EPRS1, DMRT1, CHRNB1, and CDH24 exhibits the highest specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the effector CD8-positive alpha-beta T cell-activated genes in PINNACLE. Compute the average embedding for the overlapping set, then calculate the cosine similarity between this average and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ST6GALNAC6', 'ZIC2', 'PHC1', 'CLDN12', 'CDK4']",follicular lymphoma,effector cd8-positive alpha-beta t cell,CDK4,"Which gene, among ST6GALNAC6, ZIC2, PHC1, CLDN12, and CDK4, exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene, among ST6GALNAC6, ZIC2, PHC1, CLDN12, and CDK4, exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? For follicular lymphoma, identify confirmed therapeutic targets and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with effector CD8-positive alpha-beta T cell activation genes in PINNACLE to define a subset of cell-type–specific targets. Compute the average embedding for this subset as a reference profile and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB3', 'SRP9', 'CEP170', 'LDLR', 'MICALL1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB3,"Among NDUFB3, SRP9, CEP170, LDLR, and MICALL1, which gene shows the highest cell-type specificity in effector CD8+ alpha-beta T cells for targeting follicular lymphoma?","Among NDUFB3, SRP9, CEP170, LDLR, and MICALL1, which gene shows the highest cell-type specificity in effector CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify and verify therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of the effector CD8-positive αβ T cell-activation genes in PINNACLE overlap with these targets to define a cell-type–specific target set for follicular lymphoma. Compute the average embedding for this set and calculate the cosine similarity between this reference and the embedding of each target gene. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OR2T6', 'NDUFA6', 'KRTAP3-2', 'IRF2BP2', 'PUM2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFA6,"Which gene among OR2T6, NDUFA6, KRTAP3-2, IRF2BP2, and PUM2 exhibits the highest cell-type specificity in effector CD8⁺ alpha-beta T cells for targeted intervention in follicular lymphoma?","Which gene among OR2T6, NDUFA6, KRTAP3-2, IRF2BP2, and PUM2 exhibits the highest cell-type specificity in effector CD8⁺ alpha-beta T cells for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the effector genes of CD8-positive alpha-beta T cell activation from PINNACLE. Compute the average embedding of this overlapping gene set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['NDUFAB1', 'AMPD2', 'MTHFR', 'NIBAN1', 'ABCA1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFAB1,"Which gene—NDUFAB1, AMPD2, MTHFR, NIBAN1, or ABCA1—exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeted follicular lymphoma therapy?","Which gene—NDUFAB1, AMPD2, MTHFR, NIBAN1, or ABCA1—exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the intersection with the set of effector CD8-positive alpha-beta T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these genes as a reference, then calculate the cosine similarity between this reference and each target. If one gene consistently shows a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FBXO34', 'PTMAP5', 'SSX2B', 'FRAT2', 'HDAC1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HDAC1,"Among the genes FBXO34, PTMAP5, SSX2B, FRAT2, and HDAC1, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes FBXO34, PTMAP5, SSX2B, FRAT2, and HDAC1, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Then, determine which of these targets overlap with the genes associated with activated effector CD8+ alpha-beta T cells in PINNACLE. Using this overlapping set, compute the average embedding as a reference and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance to follicular lymphoma."
"['FHIT', 'CASC3', 'FLRT1', 'WSB1', 'NDUFB5']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB5,"Which gene among FHIT, CASC3, FLRT1, WSB1, and NDUFB5 demonstrates the highest cell-type specificity in effector CD8⁺ αβ T cells for targeting follicular lymphoma?","Which gene among FHIT, CASC3, FLRT1, WSB1, and NDUFB5 demonstrates the highest cell-type specificity in effector CD8⁺ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of effector CD8-positive αβ T cell–activated genes in PINNACLE, thereby defining the cell-type–specific targets. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If a single gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-supported rationale for its biological relevance."
"['LCK', 'PVRIG', 'SLC22A3', 'PSG11', 'TEF']",follicular lymphoma,effector cd8-positive alpha-beta t cell,LCK,"Which gene among LCK, PVRIG, SLC22A3, PSG11, and TEF exhibits the highest specificity within effector CD8+ alpha-beta T cells for targeting follicular lymphoma?","Which gene among LCK, PVRIG, SLC22A3, PSG11, and TEF exhibits the highest specificity within effector CD8+ alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which effector CD8-positive αβ T cell activation genes in PINNACLE overlap with these targets, forming the cell-type-specific therapeutic set. Compute the average embedding vector for these targets and calculate the cosine similarity between this reference vector and each individual gene embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB4', 'PRPS1L1', 'AFF2', 'PANX1', 'CASTOR2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB4,"Which gene—NDUFB4, PRPS1L1, AFF2, PANX1, or CASTOR2—exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene—NDUFB4, PRPS1L1, AFF2, PANX1, or CASTOR2—exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, extract the subset of these genes that overlaps with the set of effector cd8+ αβ T cell-activated genes provided by PINNACLE. Compute the average embedding of this intersecting gene set to serve as a reference, then calculate the cosine similarity between this reference and the embedding of each individual target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND1', 'GSK3A', 'PGK2', 'C2orf42', 'PRR20D']",follicular lymphoma,effector cd8-positive alpha-beta t cell,MT-ND1,"Among MT-ND1, GSK3A, PGK2, C2orf42, and PRR20D, which gene exhibits the most specific expression in effector CD8-positive alpha-beta T cells involved in targeting follicular lymphoma?","Among MT-ND1, GSK3A, PGK2, C2orf42, and PRR20D, which gene exhibits the most specific expression in effector CD8-positive alpha-beta T cells involved in targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in effector CD8+ αβ T cells in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this target set and then compute the cosine similarity between this average and the embedding of each individual target. If one gene shows a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KRTAP5-6', 'EMC2', 'NDUFS3', 'RBM3', 'ARIH1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFS3,"Among the genes KRTAP5-6, EMC2, NDUFS3, RBM3, and ARIH1, which one exhibits the highest cell-type specificity for effector CD8-positive alpha-beta T cells involved in targeting follicular lymphoma?","Among the genes KRTAP5-6, EMC2, NDUFS3, RBM3, and ARIH1, which one exhibits the highest cell-type specificity for effector CD8-positive alpha-beta T cells involved in targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets coincide with the effector CD8+ αβ T cell-activated genes in PINNACLE. Compute the average embedding of this overlapping set as a reference signature, and then calculate the cosine similarity between this reference and each individual target gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PEX14', 'APOL4', 'PRMT7', 'HLA-DRB5', 'NINJ1']",follicular lymphoma,effector cd8-positive alpha-beta t cell,HLA-DRB5,"Which gene among PEX14, APOL4, PRMT7, HLA-DRB5, and NINJ1 exhibits the highest cell-type specificity in effector CD8+ alpha-beta T cells relevant to targeting follicular lymphoma?","Which gene among PEX14, APOL4, PRMT7, HLA-DRB5, and NINJ1 exhibits the highest cell-type specificity in effector CD8+ alpha-beta T cells relevant to targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of the effector CD8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['NPR2', 'NDUFB7', 'NXF3', 'NR2F1', 'ZNF461']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB7,"Among NPR2, NDUFB7, NXF3, NR2F1, and ZNF461, which gene demonstrates the highest cell-type specificity in effector CD8+ αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Among NPR2, NDUFB7, NXF3, NR2F1, and ZNF461, which gene demonstrates the highest cell-type specificity in effector CD8+ αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma? For follicular lymphoma, identify the verified therapeutic targets and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the activated effector CD8-positive αβ T cell genes from PINNACLE. Using this overlapping set, calculate the average embedding as a reference and compute the cosine similarity between the reference and each individual gene embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CP', 'NDUFA2', 'SLC38A6', 'HBP1', 'CEP126']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFA2,"Among the genes CP, NDUFA2, SLC38A6, HBP1, and CEP126, which displays the highest cell-type specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma?","Among the genes CP, NDUFA2, SLC38A6, HBP1, and CEP126, which displays the highest cell-type specificity for effector CD8+ αβ T cells in the context of targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the effector CD8-positive alpha-beta T cell–activated genes in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ADAMTS5', 'HCN2', 'CDH4', 'MT-ND2', 'WNT16']",follicular lymphoma,effector cd8-positive alpha-beta t cell,MT-ND2,"Among ADAMTS5, HCN2, CDH4, MT-ND2, and WNT16, which gene exhibits the highest cell-type-specific expression in effector CD8-positive αβ T cells for follicular lymphoma targeting?","Among ADAMTS5, HCN2, CDH4, MT-ND2, and WNT16, which gene exhibits the highest cell-type-specific expression in effector CD8-positive αβ T cells for follicular lymphoma targeting? Identify the experimentally verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, identify the overlap between these targets and the effector CD8+ alpha-beta T cell activated gene embeddings from PINNACLE to define the candidate gene set. Compute the average embedding for this set, then calculate the cosine similarity between this reference embedding and each individual gene embedding. Nominate the gene with a significantly higher similarity as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['RAB40B', 'NDUFB6', 'PPP1R12B', 'HIBCH', 'DCTN2']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB6,"Between RAB40B, NDUFB6, PPP1R12B, HIBCH, and DCTN2, which gene exhibits the highest cell-type specificity in effector CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Between RAB40B, NDUFB6, PPP1R12B, HIBCH, and DCTN2, which gene exhibits the highest cell-type specificity in effector CD8-positive alpha-beta T cells for targeting follicular lymphoma? Using the PINNACLE dataset, identify the cell-type–specific embeddings for verified therapeutic target genes of follicular lymphoma. Next, determine which of these targets overlap with the effector CD8-positive alpha-beta T cell-activated genes in PINNACLE. This overlapping set defines the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these targets, then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM167B', 'JAK1', 'VIL1', 'NUDCD3', 'POM121L8P']",follicular lymphoma,effector cd8-positive alpha-beta t cell,JAK1,"Which gene among TMEM167B, JAK1, VIL1, NUDCD3, and POM121L8P exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma?","Which gene among TMEM167B, JAK1, VIL1, NUDCD3, and POM121L8P exhibits the highest cell-type specificity in effector CD8+ αβ T cells for targeting follicular lymphoma? Using the PINNACLE platform, first identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, obtain the embeddings for effector CD8-positive αβ T cell-activated genes in PINNACLE and determine the overlap with the therapeutic targets to define a refined target set. Compute the average embedding of this overlap set and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB2', 'LINC01139', 'KRTAP26-1', 'AKNA', 'PLCB4']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFB2,"Among the genes NDUFB2, LINC01139, KRTAP26-1, AKNA, and PLCB4, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells relevant for targeting follicular lymphoma?","Among the genes NDUFB2, LINC01139, KRTAP26-1, AKNA, and PLCB4, which one exhibits the highest cell-type specificity in effector CD8+ αβ T cells relevant for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell‐type–specific embeddings from PINNACLE. Next, determine which effector CD8-positive αβ T cell–activated genes in PINNACLE overlap with these targets, using the overlapping set as the follicular lymphoma–specific targets. Compute the average embedding for this set and calculate the cosine similarity between this average and each individual target. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PTCD1', 'LCA5', 'METTL2A', 'ME2', 'NDUFS7']",follicular lymphoma,effector cd8-positive alpha-beta t cell,NDUFS7,"Among PTCD1, LCA5, METTL2A, ME2, and NDUFS7, which gene shows the highest cell-type specific expression in effector CD8+ αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Among PTCD1, LCA5, METTL2A, ME2, and NDUFS7, which gene shows the highest cell-type specific expression in effector CD8+ αβ T cells, thereby representing the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Then, determine which genes from the activated effector CD8-positive alpha-beta T cell population in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, and calculate the cosine similarity between the reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TNFRSF9', 'SOX13', 'NACA', 'TCTN1', 'PON2']",follicular lymphoma,cd8-positive alpha-beta t cell,TNFRSF9,"Among TNFRSF9, SOX13, NACA, TCTN1, and PON2, which gene shows the highest cell-type specificity in CD8+ αβ T cells for targeting follicular lymphoma?","Among TNFRSF9, SOX13, NACA, TCTN1, and PON2, which gene shows the highest cell-type specificity in CD8+ αβ T cells for targeting follicular lymphoma? Determine the validated therapeutic targets for follicular lymphoma and retrieve their cell‐type–specific embeddings from PINNACLE. Next, identify which of the cd8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets, forming the cell-type–specific target set for follicular lymphoma. Compute an average embedding of this set to serve as a reference, and then calculate the cosine similarity between this reference and the embedding of each target gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SHARPIN', 'PARD6G', 'B9D2', 'CUL4A', 'SFXN5']",follicular lymphoma,cd8-positive alpha-beta t cell,CUL4A,"Which gene—SHARPIN, PARD6G, B9D2, CUL4A, or SFXN5—exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene—SHARPIN, PARD6G, B9D2, CUL4A, or SFXN5—exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the literature-validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, from the set of CD8-positive alpha-beta T cell-activated genes in PINNACLE, determine the overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TLL1', 'GUCY1B1', 'GABRG1', 'SP1', 'NDUFAF1']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFAF1,"Which gene among TLL1, GUCY1B1, GABRG1, SP1, and NDUFAF1 demonstrates the highest specificity in CD8-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among TLL1, GUCY1B1, GABRG1, SP1, and NDUFAF1 demonstrates the highest specificity in CD8-positive alpha-beta T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the activated gene set in cd8-positive alpha-beta T cells within PINNACLE, defining a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes to serve as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a markedly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['MACO1', 'RPUSD3', 'RRM1', 'ECM1', 'NUFIP2']",follicular lymphoma,cd8-positive alpha-beta t cell,RRM1,"Among the genes MACO1, RPUSD3, RRM1, ECM1, and NUFIP2, which exhibits the highest specificity in CD8-positive αβ T cells, making it the most promising target for follicular lymphoma?","Among the genes MACO1, RPUSD3, RRM1, ECM1, and NUFIP2, which exhibits the highest specificity in CD8-positive αβ T cells, making it the most promising target for follicular lymphoma? Using PINNACLE, identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings. Next, determine which of these targets overlap with the set of activated cd8-positive alpha-beta T-cell genes in PINNACLE. For the overlapping genes, calculate the average embedding to serve as a reference and then compute the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['HIC2', 'INHA', 'ITPR3', 'NDUFS7', 'ALKBH7']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFS7,"Among the genes HIC2, INHA, ITPR3, NDUFS7, and ALKBH7, which exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Among the genes HIC2, INHA, ITPR3, NDUFS7, and ALKBH7, which exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Using the verified therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from PINNACLE. Identify the overlap between these targets and the set of activated CD8-positive αβ T cell genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['CLGN', 'PES1', 'FBXO9', 'MT-ND2', 'PTHLH']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND2,"Which gene among CLGN, PES1, FBXO9, MT-ND2, and PTHLH exhibits the greatest specificity for CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among CLGN, PES1, FBXO9, MT-ND2, and PTHLH exhibits the greatest specificity for CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd8-positive alpha-beta T cell-activated genes in PINNACLE, constituting the follicular lymphoma cell-type–specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual target. If one gene exhibits a substantially higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['ZFPL1', 'NDUFB5', 'CTPS1', 'SPRR3', 'TMIE']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFB5,"Among the genes ZFPL1, NDUFB5, CTPS1, SPRR3, and TMIE, which demonstrates the highest specificity for CD8+ alpha-beta T cells, making it the most promising target for follicular lymphoma?","Among the genes ZFPL1, NDUFB5, CTPS1, SPRR3, and TMIE, which demonstrates the highest specificity for CD8+ alpha-beta T cells, making it the most promising target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the genes activated in CD8-positive αβ T cells within PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping gene set as a reference vector, and then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene displays a markedly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GJA1', 'MT-ND3', 'SZRD1', 'EIF2S2', 'UQCRB']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND3,"Which gene among GJA1, MT-ND3, SZRD1, EIF2S2, and UQCRB exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene among GJA1, MT-ND3, SZRD1, EIF2S2, and UQCRB exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which cd8-positive αβ T cell–activated genes in PINNACLE intersect with these targets to define a follicular lymphoma–specific target set. Compute the average embedding of this set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LARP1B', 'AGPAT5', 'HLA-DRB5', 'MTF1', 'FTL']",follicular lymphoma,cd8-positive alpha-beta t cell,HLA-DRB5,"Among LARP1B, AGPAT5, HLA-DRB5, MTF1, and FTL, which gene exhibits the highest specificity in CD8-positive αβ T cells as a potential target for follicular lymphoma?","Among LARP1B, AGPAT5, HLA-DRB5, MTF1, and FTL, which gene exhibits the highest specificity in CD8-positive αβ T cells as a potential target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which targets overlap with CD8-positive αβ T cell activation genes from PINNACLE. Compute the average embedding for the overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLD1', 'FAM172A', 'SNRPE', 'HIGD1C', 'ZNF302']",follicular lymphoma,cd8-positive alpha-beta t cell,POLD1,"Which gene among POLD1, FAM172A, SNRPE, HIGD1C, and ZNF302 exhibits the highest specificity for CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among POLD1, FAM172A, SNRPE, HIGD1C, and ZNF302 exhibits the highest specificity for CD8-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, extract the cd8-positive, alpha-beta T cell activation gene embeddings from PINNACLE and determine the overlap with the follicular lymphoma targets. Using this overlapping set, compute the average embedding and calculate the cosine similarity between this reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the rest, nominate it as the top candidate and provide a brief, evidence-based explanation of its biological relevance."
"['NUP43', 'IMPDH1', 'AMBP', 'LGALS1', 'TTC21A']",follicular lymphoma,cd8-positive alpha-beta t cell,IMPDH1,"Which gene from the list NUP43, IMPDH1, AMBP, LGALS1, and TTC21A exhibits the highest specificity of expression in CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene from the list NUP43, IMPDH1, AMBP, LGALS1, and TTC21A exhibits the highest specificity of expression in CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd8-positive αβ T cell activation genes in PINNACLE, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a substantially higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZBTB39', 'MUC1', 'INTS1', 'ZNF526', 'CD3D']",follicular lymphoma,cd8-positive alpha-beta t cell,CD3D,"Among the genes ZBTB39, MUC1, INTS1, ZNF526, and CD3D, which shows the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Among the genes ZBTB39, MUC1, INTS1, ZNF526, and CD3D, which shows the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, identify which cd8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of these overlapping targets and compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a concise evidence-based rationale for its biological relevance."
"['ARL2', 'IQCC', 'NMU', 'NCAN', 'NDUFB1']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFB1,"Among the genes ARL2, IQCC, NMU, NCAN, and NDUFB1, which one exhibits the highest cell-type specificity in CD8+ alpha-beta T cells and is the best candidate for targeting follicular lymphoma?","Among the genes ARL2, IQCC, NMU, NCAN, and NDUFB1, which one exhibits the highest cell-type specificity in CD8+ alpha-beta T cells and is the best candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which CD8-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets to define a cell-type–specific target set for follicular lymphoma. Then, compute the average embedding of these overlapping targets and calculate the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['CIDEA', 'IMPDH2', 'SP1', 'AKAP8', 'DAPL1']",follicular lymphoma,cd8-positive alpha-beta t cell,IMPDH2,"Which gene among CIDEA, IMPDH2, SP1, AKAP8, and DAPL1 exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma?","Which gene among CIDEA, IMPDH2, SP1, AKAP8, and DAPL1 exhibits the highest cell-type specificity in CD8-positive αβ T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma within the PINNACLE database and retrieve their corresponding cell-type specific embeddings. Next, intersect these targets with the set of CD8-positive αβ T cell-activated genes from PINNACLE to define the cell-type specific targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MRPS17', 'ATP1B1', 'OTUB2', 'IFNAR2', 'KLK3']",follicular lymphoma,cd8-positive alpha-beta t cell,IFNAR2,"Among the following genes—MRPS17, ATP1B1, OTUB2, IFNAR2, and KLK3—which one exhibits the highest cell-type specificity in CD8+ alpha-beta T cells for use as a targeted candidate in follicular lymphoma therapy?","Among the following genes—MRPS17, ATP1B1, OTUB2, IFNAR2, and KLK3—which one exhibits the highest cell-type specificity in CD8+ alpha-beta T cells for use as a targeted candidate in follicular lymphoma therapy? Retrieve validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the CD8-positive alpha-beta T cell–activated genes in PINNACLE. For this overlapping set, compute the average embedding and then determine the cosine similarity between this reference and each gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LY6D', 'SRARP', 'TTC27', 'MSMO1', 'NDUFAF4']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFAF4,"Among the genes LY6D, SRARP, TTC27, MSMO1, and NDUFAF4, which exhibits the most specific expression profile in CD8+ αβ T cells relevant for targeting follicular lymphoma?","Among the genes LY6D, SRARP, TTC27, MSMO1, and NDUFAF4, which exhibits the most specific expression profile in CD8+ αβ T cells relevant for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and genes activated in CD8-positive alpha-beta T cells within PINNACLE. Compute the average embedding of the overlapping gene set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HHLA3', 'OSBPL2', 'MT-ND4', 'OTOF', 'SHD']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND4,"Among HHLA3, OSBPL2, MT-ND4, OTOF, and SHD, which gene exhibits the highest specificity of expression in CD8+ alpha-beta T cells for potential targeting in follicular lymphoma?","Among HHLA3, OSBPL2, MT-ND4, OTOF, and SHD, which gene exhibits the highest specificity of expression in CD8+ alpha-beta T cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and, using the PINNACLE database, extract their cell-type–specific embeddings. Next, determine which of these targets overlap with the set of cd8-positive alpha-beta T cell activation genes in PINNACLE to compile a list of cell-type–specific targets for follicular lymphoma. Calculate the average embedding of these targets as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TRIT1', 'HSD17B11', 'PTPA', 'POLA1', 'GFI1B']",follicular lymphoma,cd8-positive alpha-beta t cell,POLA1,"Among the genes TRIT1, HSD17B11, PTPA, POLA1, and GFI1B, which one exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Among the genes TRIT1, HSD17B11, PTPA, POLA1, and GFI1B, which one exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of CD8-positive alpha-beta T cell–activated genes available in PINNACLE, defining the cell-type–specific targets for follicular lymphoma. Then, compute the average embedding for this overlapping gene set, and calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, providing a brief, evidence-based rationale for its biological relevance."
"['ZHX3', 'CCNH', 'FSTL1', 'NDUFA6', 'PIGM']",follicular lymphoma,cd8-positive alpha-beta t cell,NDUFA6,"Among the candidate genes ZHX3, CCNH, FSTL1, NDUFA6, and PIGM, which one exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma?","Among the candidate genes ZHX3, CCNH, FSTL1, NDUFA6, and PIGM, which one exhibits the highest cell-type specificity in CD8-positive alpha-beta T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell‐type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the genes activated in CD8-positive alpha-beta T cells in PINNACLE, defining this overlapping set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['RAPGEF3', 'MT-ND1', 'ECHDC2', 'TREM1', 'HES7']",follicular lymphoma,cd8-positive alpha-beta t cell,MT-ND1,"Among the candidate genes (RAPGEF3, MT-ND1, ECHDC2, TREM1, HES7), which one exhibits the highest cell-type specificity in CD8-positive αβ T cells and is most promising for targeting follicular lymphoma?","Among the candidate genes (RAPGEF3, MT-ND1, ECHDC2, TREM1, HES7), which one exhibits the highest cell-type specificity in CD8-positive αβ T cells and is most promising for targeting follicular lymphoma? Determine the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Identify which of these targets overlap with the cd8-positive αβ T cell activation genes present in PINNACLE. Next, compute the average embedding of the overlapping set and calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['LOX', 'INTS1', 'NIPBL', 'HDAC7', 'SIN3A']",follicular lymphoma,t follicular helper cell,HDAC7,"Which gene among LOX, INTS1, NIPBL, HDAC7, and SIN3A exhibits the highest specificity in T follicular helper cells, thereby serving as the most suitable candidate for targeted follicular lymphoma treatment?","Which gene among LOX, INTS1, NIPBL, HDAC7, and SIN3A exhibits the highest specificity in T follicular helper cells, thereby serving as the most suitable candidate for targeted follicular lymphoma treatment? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Then, determine which of these targets overlap with t follicular helper cell–activated genes in PINNACLE, yielding the cell-type–specific targets for follicular lymphoma. For these overlapping genes, compute their average embedding and calculate the cosine similarity between this reference and each gene’s individual embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PACSIN3', 'UBE2E4P', 'CXCL5', 'ANKIB1', 'CD3G']",follicular lymphoma,t follicular helper cell,CD3G,"Which gene among PACSIN3, UBE2E4P, CXCL5, ANKIB1, and CD3G is most specifically expressed in T follicular helper cells, making it the best candidate for targeting follicular lymphoma?","Which gene among PACSIN3, UBE2E4P, CXCL5, ANKIB1, and CD3G is most specifically expressed in T follicular helper cells, making it the best candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which t follicular helper cell–activated genes in PINNACLE overlap with these targets. For the overlapping genes, compute an average embedding as a reference and calculate the cosine similarity between this reference and each gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB9', 'SLC4A1', 'CLIC2', 'NAIP', 'GSTO2']",follicular lymphoma,t follicular helper cell,NDUFB9,"Which gene among NDUFB9, SLC4A1, CLIC2, NAIP, and GSTO2 exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma?","Which gene among NDUFB9, SLC4A1, CLIC2, NAIP, and GSTO2 exhibits the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of t follicular helper cell–activated genes in PINNACLE. Using the overlapping genes, compute the average embedding as a reference, and then calculate the cosine similarity between this reference and each individual gene's embedding. If one gene displays a significantly higher cosine similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['RAB11FIP1', 'CRYAA2', 'RRM1', 'KRBOX4', 'ZC3H7B']",follicular lymphoma,t follicular helper cell,RRM1,"Which gene among RAB11FIP1, CRYAA2, RRM1, KRBOX4, and ZC3H7B exhibits the highest specificity for T follicular helper cells in the context of targeted follicular lymphoma therapy?","Which gene among RAB11FIP1, CRYAA2, RRM1, KRBOX4, and ZC3H7B exhibits the highest specificity for T follicular helper cells in the context of targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Then, determine which t follicular helper cell-activated genes in PINNACLE overlap with these targets. Next, compute the average embedding of the overlapping gene set and calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SHOX', 'NDUFA7', 'FUNDC2', 'CAMKK2', 'BRD4']",follicular lymphoma,t follicular helper cell,NDUFA7,"Which gene among SHOX, NDUFA7, FUNDC2, CAMKK2, and BRD4 exhibits the highest specificity of expression in T follicular helper cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among SHOX, NDUFA7, FUNDC2, CAMKK2, and BRD4 exhibits the highest specificity of expression in T follicular helper cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the T follicular helper cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CLEC4C', 'ZNF227', 'COL26A1', 'ANGPTL4', 'TYK2']",follicular lymphoma,t follicular helper cell,TYK2,"Among the genes CLEC4C, ZNF227, COL26A1, ANGPTL4, and TYK2, which one shows the highest specificity of expression in T follicular helper cells, making it the best candidate for targeting follicular lymphoma?","Among the genes CLEC4C, ZNF227, COL26A1, ANGPTL4, and TYK2, which one shows the highest specificity of expression in T follicular helper cells, making it the best candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which t follicular helper cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. Finally, if one gene exhibits significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC10', 'TRIM34', 'AGL', 'PRPF38A', 'ZSCAN22']",follicular lymphoma,t follicular helper cell,HDAC10,"Among the genes HDAC10, TRIM34, AGL, PRPF38A, and ZSCAN22, which exhibits the highest specificity in T follicular helper cells and represents the most promising candidate for targeting follicular lymphoma?","Among the genes HDAC10, TRIM34, AGL, PRPF38A, and ZSCAN22, which exhibits the highest specificity in T follicular helper cells and represents the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the subset of these targets that overlap with t follicular helper cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PTCD1', 'NDUFAF3', 'HLA-E', 'ZCCHC8', 'UBE2G2']",follicular lymphoma,t follicular helper cell,NDUFAF3,"Which gene among PTCD1, NDUFAF3, HLA-E, ZCCHC8, and UBE2G2 demonstrates the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma?","Which gene among PTCD1, NDUFAF3, HLA-E, ZCCHC8, and UBE2G2 demonstrates the highest cell-type specificity in T follicular helper cells for targeting follicular lymphoma? Using the PINNACLE dataset, first identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific gene embeddings. Next, determine the overlap between these targets and the T follicular helper cell–activated genes in PINNACLE to establish the relevant target set. Calculate the average embedding for this set and compute the cosine similarity between the average and each target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the primary candidate and provide a concise, evidence-based explanation for its biological relevance."
"['C7orf25', 'HCFC1', 'LINC00839', 'PSMB5', 'PLSCR3']",follicular lymphoma,t follicular helper cell,PSMB5,"Among C7orf25, HCFC1, LINC00839, PSMB5, and PLSCR3, which gene exhibits the highest expression specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma?","Among C7orf25, HCFC1, LINC00839, PSMB5, and PLSCR3, which gene exhibits the highest expression specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with T follicular helper cell-activated genes in the database to define a subset of follicular lymphoma–specific targets. Compute the average embedding for this subset as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CACYBP', 'CFAP58', 'COG4', 'NR3C1', 'SFR1']",follicular lymphoma,t follicular helper cell,NR3C1,"Among CACYBP, CFAP58, COG4, NR3C1, and SFR1, which gene exhibits the highest T follicular helper cell specificity as a potential target for follicular lymphoma?","Among CACYBP, CFAP58, COG4, NR3C1, and SFR1, which gene exhibits the highest T follicular helper cell specificity as a potential target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE resource. Next, determine which of the T follicular helper cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Calculate the average embedding for this overlapping set as a reference and compute the cosine similarity between this reference and each individual target’s embedding. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PIGS', 'JADE2', 'NDUFS2', 'RO60', 'HSF4']",follicular lymphoma,t follicular helper cell,NDUFS2,"Among the genes PIGS, JADE2, NDUFS2, RO60, and HSF4, which one exhibits the highest cell-type specificity in T follicular helper cells for potential targeted therapy in follicular lymphoma?","Among the genes PIGS, JADE2, NDUFS2, RO60, and HSF4, which one exhibits the highest cell-type specificity in T follicular helper cells for potential targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in T follicular helper cells in PINNACLE; this overlapping set defines the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this set to serve as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC22A6', 'SMIM5', 'MT-ND4', 'C14orf93', 'ULK1']",follicular lymphoma,t follicular helper cell,MT-ND4,"Which gene among SLC22A6, SMIM5, MT-ND4, C14orf93, and ULK1 exhibits the highest specificity for T follicular helper cells, thereby representing the most promising target for follicular lymphoma?","Which gene among SLC22A6, SMIM5, MT-ND4, C14orf93, and ULK1 exhibits the highest specificity for T follicular helper cells, thereby representing the most promising target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which t follicular helper cell-activated genes in PINNACLE intersect with these targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, and then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a markedly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['CUL4A', 'PTCH1', 'RSU1', 'KLRC3', 'ORC2']",follicular lymphoma,t follicular helper cell,CUL4A,"Which gene among CUL4A, PTCH1, RSU1, KLRC3, and ORC2 exhibits the highest specificity for T follicular helper cells, making it the most suitable target for follicular lymphoma therapy?","Which gene among CUL4A, PTCH1, RSU1, KLRC3, and ORC2 exhibits the highest specificity for T follicular helper cells, making it the most suitable target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, find the intersection of these targets with the t follicular helper cell-activated genes in PINNACLE. For this overlapping set, compute the average embedding and then calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRKAA1', 'LAG3', 'MRPL14', 'GRK6', 'C8orf48']",follicular lymphoma,t follicular helper cell,LAG3,"Among the genes PRKAA1, LAG3, MRPL14, GRK6, and C8orf48, which one shows the highest specificity in T follicular helper cells for potential targeting in follicular lymphoma?","Among the genes PRKAA1, LAG3, MRPL14, GRK6, and C8orf48, which one shows the highest specificity in T follicular helper cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the t follicular helper cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this reference and each individual target. If one gene consistently shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['H2AC17', 'RAB22A', 'DCBLD1', 'R3HDM1', 'CD38']",follicular lymphoma,t follicular helper cell,CD38,"Which gene—H2AC17, RAB22A, DCBLD1, R3HDM1, or CD38—displays the highest specificity of expression in T follicular helper cells, making it the most promising target for follicular lymphoma?","Which gene—H2AC17, RAB22A, DCBLD1, R3HDM1, or CD38—displays the highest specificity of expression in T follicular helper cells, making it the most promising target for follicular lymphoma? Identify functionally validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with t follicular helper cell–activated genes in PINNACLE to define the cell-type–specific targets. Calculate the average embedding for the overlapping set as a reference, then compute the cosine similarity between this reference and each target's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SERF2', 'MCL1', 'IGL', 'SHROOM3', 'FLOT2']",follicular lymphoma,t follicular helper cell,MCL1,"Among the genes SERF2, MCL1, IGL, SHROOM3, and FLOT2, which one shows the highest specificity in T follicular helper cells and emerges as the most promising target for follicular lymphoma?","Among the genes SERF2, MCL1, IGL, SHROOM3, and FLOT2, which one shows the highest specificity in T follicular helper cells and emerges as the most promising target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which of these targets overlap with t follicular helper cell-activated genes in PINNACLE to define the cell-type-specific targets. Calculate the average embedding for this set and compute the cosine similarity between this reference embedding and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCDC78', 'RUSF1', 'POLD2', 'TBX6', 'DRG2']",follicular lymphoma,t follicular helper cell,POLD2,"Among the genes CCDC78, RUSF1, POLD2, TBX6, and DRG2, which one demonstrates the highest specificity for T follicular helper cells in the context of targeting follicular lymphoma?","Among the genes CCDC78, RUSF1, POLD2, TBX6, and DRG2, which one demonstrates the highest specificity for T follicular helper cells in the context of targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which t follicular helper cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and compute the cosine similarity between this average and each individual gene's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SSR3', 'BPIFB3', 'BMPR1A', 'NDUFA5', 'FOXRED2']",follicular lymphoma,t follicular helper cell,NDUFA5,"Among the genes SSR3, BPIFB3, BMPR1A, NDUFA5, and FOXRED2, which one demonstrates the highest specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma therapy?","Among the genes SSR3, BPIFB3, BMPR1A, NDUFA5, and FOXRED2, which one demonstrates the highest specificity in T follicular helper cells, thereby representing the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the T follicular helper cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Calculate the average embedding for this set and then compute the cosine similarity between this reference embedding and each individual target’s embedding. Finally, if one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ARL6', 'AZU1', 'MNAT1', 'NDUFB10', 'CACTIN']",follicular lymphoma,t follicular helper cell,NDUFB10,"Among ARL6, AZU1, MNAT1, NDUFB10, and CACTIN, which gene exhibits the most specific expression in T follicular helper cells for targeting follicular lymphoma?","Among ARL6, AZU1, MNAT1, NDUFB10, and CACTIN, which gene exhibits the most specific expression in T follicular helper cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and t follicular helper cell-activated genes in PINNACLE, defining the set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set and calculate the cosine similarity between this average and each individual gene embedding. If a single gene shows markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND5', 'KLHL22', 'FOXC2', 'CDKN2C', 'ZNF131']",follicular lymphoma,t follicular helper cell,MT-ND5,"Among the genes MT-ND5, KLHL22, FOXC2, CDKN2C, and ZNF131, which one exhibits the highest cell-type specificity in T follicular helper cells as a target for follicular lymphoma?","Among the genes MT-ND5, KLHL22, FOXC2, CDKN2C, and ZNF131, which one exhibits the highest cell-type specificity in T follicular helper cells as a target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the t follicular helper cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference vector and each individual target. If one gene displays substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LMBR1', 'TROAP', 'EZH2', 'CFL2', 'CXCL12']",follicular lymphoma,cd4-positive alpha-beta t cell,EZH2,"Among the genes LMBR1, TROAP, EZH2, CFL2, and CXCL12, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for use in targeting follicular lymphoma?","Among the genes LMBR1, TROAP, EZH2, CFL2, and CXCL12, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for use in targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta T cell-activated genes in PINNACLE, defining this intersection as the cell-type–specific targets for follicular lymphoma. Compute the average embedding from this overlapping set as a reference, and then calculate the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IFT140', 'AUH', 'IPO5', 'HNRNPUL2', 'NDUFC2']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFC2,"Which gene among IFT140, AUH, IPO5, HNRNPUL2, and NDUFC2 exhibits the highest cell-type specificity in CD4-positive αβ T cells, making it the best candidate for targeted therapy in follicular lymphoma?","Which gene among IFT140, AUH, IPO5, HNRNPUL2, and NDUFC2 exhibits the highest cell-type specificity in CD4-positive αβ T cells, making it the best candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd4-positive αβ T cell–activated genes from PINNACLE, thus defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for the overlapping set to serve as a reference, and then compute the cosine similarity between this reference and each individual target gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDK7', 'SPIRE2', 'CLN3', 'TFDP1', 'MKNK1']",follicular lymphoma,cd4-positive alpha-beta t cell,CDK7,"Among the genes CDK7, SPIRE2, CLN3, TFDP1, and MKNK1, which one shows the highest specificity for CD4-positive alpha-beta T cells, making it the best candidate for targeting follicular lymphoma?","Among the genes CDK7, SPIRE2, CLN3, TFDP1, and MKNK1, which one shows the highest specificity for CD4-positive alpha-beta T cells, making it the best candidate for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in CD4-positive alpha-beta T cells from PINNACLE, as these overlapping genes represent cell-type-specific targets. Compute the average embedding of the overlapping set and calculate the cosine similarity between this average and each individual gene embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ECRG4', 'GABARAPL3', 'IL2RB', 'HTR1B', 'SDK1']",follicular lymphoma,cd4-positive alpha-beta t cell,IL2RB,"Among the genes ECRG4, GABARAPL3, IL2RB, HTR1B, and SDK1, which one exhibits the highest specificity in CD4-positive αβ T cells for targeted intervention in follicular lymphoma?","Among the genes ECRG4, GABARAPL3, IL2RB, HTR1B, and SDK1, which one exhibits the highest specificity in CD4-positive αβ T cells for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, from the set of CD4-positive alpha-beta T cell–activated genes in PINNACLE, identify those that overlap with the lymphoma targets. Calculate the average embedding of these overlapping genes to serve as a reference, and then compute the cosine similarity between this reference and each individual target gene. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DHX16', 'PARVA', 'NDUFS3', 'SIRPG', 'RTKN']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFS3,"Among the genes DHX16, PARVA, NDUFS3, SIRPG, and RTKN, which exhibits the highest cell type specificity in CD4-positive αβ T cells, making it the best candidate for targeted therapy in follicular lymphoma?","Among the genes DHX16, PARVA, NDUFS3, SIRPG, and RTKN, which exhibits the highest cell type specificity in CD4-positive αβ T cells, making it the best candidate for targeted therapy in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta T cell activation genes in PINNACLE, as this intersection defines your cell-type–specific targets. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference vector and the embedding of each individual target gene. If one gene displays a markedly higher similarity compared to the others, nominate it as the top candidate, providing a concise, evidence-based rationale for its biological relevance."
"['PPT1', 'TLR5', 'KLRD1', 'DPP4', 'POLD2']",follicular lymphoma,cd4-positive alpha-beta t cell,POLD2,"Which gene among PPT1, TLR5, KLRD1, DPP4, and POLD2 demonstrates the highest cell-type specificity in CD4-positive alpha-beta T cells, positioning it as the most promising target for follicular lymphoma?","Which gene among PPT1, TLR5, KLRD1, DPP4, and POLD2 demonstrates the highest cell-type specificity in CD4-positive alpha-beta T cells, positioning it as the most promising target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the CD4-positive alpha-beta T cell-activated genes in PINNACLE to define a cell-type–specific target set. Calculate the average embedding of this overlapping set to serve as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['STRAP', 'CXCL5', 'CHD1L', 'GTPBP3', 'IMPDH1']",follicular lymphoma,cd4-positive alpha-beta t cell,IMPDH1,"Which gene among STRAP, CXCL5, CHD1L, GTPBP3, and IMPDH1 exhibits the most specific expression in CD4+ αβ T cells, making it the best candidate for targeting follicular lymphoma?","Which gene among STRAP, CXCL5, CHD1L, GTPBP3, and IMPDH1 exhibits the most specific expression in CD4+ αβ T cells, making it the best candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the CD4-positive alpha-beta T cell-activated genes in PINNACLE to define follicular lymphoma-specific targets. Compute the average embedding of the overlapping genes and calculate the cosine similarity between this average and each target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['PPIA', 'RAB25', 'TSPAN13', 'ARMCX3', 'CAMK2B']",follicular lymphoma,cd4-positive alpha-beta t cell,PPIA,"Among the following genes—PPIA, RAB25, TSPAN13, ARMCX3, and CAMK2B—which exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for potential targeting in follicular lymphoma?","Among the following genes—PPIA, RAB25, TSPAN13, ARMCX3, and CAMK2B—which exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, identify which of the cd4-positive alpha-beta T cell–activated genes in PINNACLE overlap with these targets to define the cell-specific target set for follicular lymphoma. Calculate the average embedding of these overlapping genes as a reference and compute the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SEPTIN3', 'TP53INP2', 'CD3D', 'POMK', 'LSM10']",follicular lymphoma,cd4-positive alpha-beta t cell,CD3D,"Among the genes SEPTIN3, TP53INP2, CD3D, POMK, and LSM10, which exhibits the highest cell-type specificity within CD4+ αβ T cells for targeting follicular lymphoma?","Among the genes SEPTIN3, TP53INP2, CD3D, POMK, and LSM10, which exhibits the highest cell-type specificity within CD4+ αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the cd4-positive, alpha-beta T cell–activated genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SLC35A1', 'CHD1L', 'MT-ND5', 'UQCRH', 'IRF4']",follicular lymphoma,cd4-positive alpha-beta t cell,MT-ND5,"Which gene among SLC35A1, CHD1L, MT-ND5, UQCRH, and IRF4 displays the highest expression specificity in CD4-positive alpha-beta T cells, making it the best candidate for targeting follicular lymphoma?","Which gene among SLC35A1, CHD1L, MT-ND5, UQCRH, and IRF4 displays the highest expression specificity in CD4-positive alpha-beta T cells, making it the best candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the CD4-positive alpha-beta T cell-activated genes available in PINNACLE overlap with these targets, defining the cell-type–specific target set for follicular lymphoma. Compute the average embedding of this overlapping set, then calculate the cosine similarity between this average and each individual gene’s embedding. If one gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PTP4A3', 'KMT2C', 'FAM110C', 'DDO', 'TOP2B']",follicular lymphoma,cd4-positive alpha-beta t cell,TOP2B,"Among PTP4A3, KMT2C, FAM110C, DDO, and TOP2B, which gene exhibits the highest cell-type specificity in CD4-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma?","Among PTP4A3, KMT2C, FAM110C, DDO, and TOP2B, which gene exhibits the highest cell-type specificity in CD4-positive αβ T cells, making it the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and genes activated in CD4-positive alpha-beta T cells within PINNACLE, designating the shared set as the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these genes to serve as a reference profile, then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a notably higher similarity score than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC8', 'IFIH1', 'HEY2', 'IFT46', 'HLTF']",follicular lymphoma,cd4-positive alpha-beta t cell,HDAC8,"Which gene among HDAC8, IFIH1, HEY2, IFT46, and HLTF exhibits the highest cell-type specific expression in CD4-positive αβ T cells for targeting follicular lymphoma?","Which gene among HDAC8, IFIH1, HEY2, IFT46, and HLTF exhibits the highest cell-type specific expression in CD4-positive αβ T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of CD4-positive αβ T cell-activated gene embeddings available in PINNACLE; this overlapping set will represent the cell-type-specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If a single gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['OXTR', 'UBE2U', 'SCUBE2', 'CYTH1', 'CCR5']",follicular lymphoma,cd4-positive alpha-beta t cell,CCR5,"Which gene among OXTR, UBE2U, SCUBE2, CYTH1, and CCR5 exhibits the highest cell-type specificity in CD4+ αβ T cells for potential therapeutic targeting in follicular lymphoma?","Which gene among OXTR, UBE2U, SCUBE2, CYTH1, and CCR5 exhibits the highest cell-type specificity in CD4+ αβ T cells for potential therapeutic targeting in follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, identify which of these targets overlap with the cd4-positive alpha-beta T cell-activated genes in PINNACLE to generate a list of relevant cell-type–specific targets. Compute the average embedding for this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and the individual gene embeddings. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LCMT1', 'TRIM47', 'TBX15', 'DCK', 'CDK1']",follicular lymphoma,cd4-positive alpha-beta t cell,CDK1,"Among the genes LCMT1, TRIM47, TBX15, DCK, and CDK1, which one exhibits the highest cell-type specificity in CD4+ αβ T cells relevant to follicular lymphoma for potential targeted therapy?","Among the genes LCMT1, TRIM47, TBX15, DCK, and CDK1, which one exhibits the highest cell-type specificity in CD4+ αβ T cells relevant to follicular lymphoma for potential targeted therapy? Identify the verified therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in CD4-positive αβ T cells overlap with these targets, as this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PDHX', 'HSP90AA1', 'TNFAIP8L1', 'BMS1', 'KDM5A']",follicular lymphoma,cd4-positive alpha-beta t cell,HSP90AA1,"Which gene among PDHX, HSP90AA1, TNFAIP8L1, BMS1, and KDM5A exhibits the highest cell-type specificity in CD4+ αβ T cells for potential targeting in follicular lymphoma?","Which gene among PDHX, HSP90AA1, TNFAIP8L1, BMS1, and KDM5A exhibits the highest cell-type specificity in CD4+ αβ T cells for potential targeting in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in CD4-positive alpha-beta T cells as defined in PINNACLE. Using this overlapping set as the cell-type–specific targets for follicular lymphoma, compute their average embedding as a reference point, and then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['TRPM1', 'ITPA', 'LRRIQ1', 'TMEM8B', 'NDUFB7']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFB7,"Among the genes TRPM1, ITPA, LRRIQ1, TMEM8B, and NDUFB7, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Among the genes TRPM1, ITPA, LRRIQ1, TMEM8B, and NDUFB7, which one exhibits the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which CD4-positive αβ T cell activation genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['UNC50', 'MXD3', 'LYST', 'SLC6A15', 'NDUFB6']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFB6,"Which gene, among UNC50, MXD3, LYST, SLC6A15, and NDUFB6, shows the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma?","Which gene, among UNC50, MXD3, LYST, SLC6A15, and NDUFB6, shows the highest cell-type specificity in CD4-positive alpha-beta T cells for targeting follicular lymphoma? Using PINNACLE, identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings. Next, determine which CD4-positive, alpha-beta T cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific targets. Compute the mean embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual gene embedding. Finally, if one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HDAC7', 'MIA3', 'MAPKBP1', 'NHLH1', 'TMEM80']",follicular lymphoma,cd4-positive alpha-beta t cell,HDAC7,"Which gene among HDAC7, MIA3, MAPKBP1, NHLH1, and TMEM80 demonstrates the highest cell-type specificity in CD4-positive αβ T cells, making it a promising target for follicular lymphoma?","Which gene among HDAC7, MIA3, MAPKBP1, NHLH1, and TMEM80 demonstrates the highest cell-type specificity in CD4-positive αβ T cells, making it a promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the cd4-positive alpha-beta T cell activation genes available in PINNACLE. Calculate the average embedding for this overlapping set to serve as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SNRPA1', 'CELF6', 'NDUFAB1', 'ATP6V1C2', 'CAP1']",follicular lymphoma,cd4-positive alpha-beta t cell,NDUFAB1,"Among the genes SNRPA1, CELF6, NDUFAB1, ATP6V1C2, and CAP1, which exhibits the highest cell-type-specific expression in CD4+ αβ T cells relevant for targeting follicular lymphoma?","Among the genes SNRPA1, CELF6, NDUFAB1, ATP6V1C2, and CAP1, which exhibits the highest cell-type-specific expression in CD4+ αβ T cells relevant for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell‐type–specific embeddings from PINNACLE. Then, determine the overlap between these targets and the set of genes activated in CD4-positive αβ T cells within PINNACLE. Next, compute the average embedding of the overlapping gene set and calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC3', 'SUSD3', 'ZC3H18', 'NPTX2', 'SLC30A7']",follicular lymphoma,cd4-positive alpha-beta t cell,HDAC3,"Which gene among HDAC3, SUSD3, ZC3H18, NPTX2, and SLC30A7 exhibits the highest cell-type specificity in CD4+ alpha–beta T cells for applications in targeting follicular lymphoma?","Which gene among HDAC3, SUSD3, ZC3H18, NPTX2, and SLC30A7 exhibits the highest cell-type specificity in CD4+ alpha–beta T cells for applications in targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the cd4-positive alpha-beta T cell-activated genes in PINNACLE overlap with these targets to define the cell-type-specific therapeutic set. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['TRIM15', 'HSP90AA1', 'CECR2', 'SNRPN', 'CHRM4']",follicular lymphoma,regulatory t cell,HSP90AA1,"Among the following genes—TRIM15, HSP90AA1, CECR2, SNRPN, and CHRM4—which gene exhibits the highest specificity in regulatory T cells, making it the best candidate for targeting follicular lymphoma?","Among the following genes—TRIM15, HSP90AA1, CECR2, SNRPN, and CHRM4—which gene exhibits the highest specificity in regulatory T cells, making it the best candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for the disease. Calculate the average embedding for this overlapping gene set, then compute the cosine similarity between this average embedding and each individual target gene. Finally, nominate the gene with a markedly higher similarity score as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS4', 'C12orf40', 'MYO7A', 'RMND5A', 'CDC20']",follicular lymphoma,regulatory t cell,NDUFS4,"Which gene among NDUFS4, C12orf40, MYO7A, RMND5A, and CDC20 exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Which gene among NDUFS4, C12orf40, MYO7A, RMND5A, and CDC20 exhibits the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Then, determine the intersection between these targets and the regulatory T cell–activated genes in PINNACLE to define the relevant cell-type targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['YRDC', 'CLDN15', 'MS4A6A', 'IL2RA', 'TMED5']",follicular lymphoma,regulatory t cell,IL2RA,"Among the following genes—YRDC, CLDN15, MS4A6A, IL2RA, and TMED5—which one demonstrates the highest specificity in regulatory T cells for targeting follicular lymphoma?","Among the following genes—YRDC, CLDN15, MS4A6A, IL2RA, and TMED5—which one demonstrates the highest specificity in regulatory T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and acquire their cell-type–specific embeddings from PINNACLE. Next, determine which of the regulatory T cell-activated genes in PINNACLE overlap with these targets, hence defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlap group to serve as a reference, and then calculate the cosine similarity between the reference and each individual target. If one gene displays a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['C5orf38', 'NUDT3', 'WNK4', 'MT-ND3', 'PSMD10']",follicular lymphoma,regulatory t cell,MT-ND3,"Among the genes C5orf38, NUDT3, WNK4, MT-ND3, and PSMD10, which one exhibits the highest cell-type specificity in regulatory T cells for potential targeting in follicular lymphoma?","Among the genes C5orf38, NUDT3, WNK4, MT-ND3, and PSMD10, which one exhibits the highest cell-type specificity in regulatory T cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the regulatory T cell–activated genes from PINNACLE intersect with these targets to generate a set of cell-type–specific targets. Compute the average embedding of this set as a reference and calculate the cosine similarity between this reference and each individual target's embedding. If one gene exhibits substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['FBXW7', 'ZNF138', 'ZNF451', 'HDAC7', 'CHRNG']",follicular lymphoma,regulatory t cell,HDAC7,"Which gene—FBXW7, ZNF138, ZNF451, HDAC7, or CHRNG—exhibits the highest cell-type specificity in regulatory T cells for potential targeting in follicular lymphoma?","Which gene—FBXW7, ZNF138, ZNF451, HDAC7, or CHRNG—exhibits the highest cell-type specificity in regulatory T cells for potential targeting in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets to obtain a set of cell-type–specific targets for the disease. Calculate the average embedding of this overlapping set as a reference, and compute the cosine similarity between this reference and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CAST', 'KSR2', 'HPF1', 'NDUFC1', 'ZSCAN30']",follicular lymphoma,regulatory t cell,NDUFC1,"Among the genes CAST, KSR2, HPF1, NDUFC1, and ZSCAN30, which one shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Among the genes CAST, KSR2, HPF1, NDUFC1, and ZSCAN30, which one shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Which verified therapeutic targets for follicular lymphoma have associated cell-type–specific embeddings in the PINNACLE dataset? Among these, which targets overlap with regulatory T cell–activated genes in PINNACLE, thereby representing the cell-type–specific targets for follicular lymphoma? Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['KLHL3', 'GHRHR', 'UQCC2', 'MT-ND4L', 'KRTAP1-3']",follicular lymphoma,regulatory t cell,MT-ND4L,"Which gene among KLHL3, GHRHR, UQCC2, MT-ND4L, and KRTAP1-3 exhibits the highest cell-type specificity in regulatory T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among KLHL3, GHRHR, UQCC2, MT-ND4L, and KRTAP1-3 exhibits the highest cell-type specificity in regulatory T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the regulatory T cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['POLR3GL', 'NDUFA8', 'MAG', 'TNFAIP1', 'GATA6']",follicular lymphoma,regulatory t cell,NDUFA8,"Among the genes POLR3GL, NDUFA8, MAG, TNFAIP1, and GATA6, which exhibits the highest specificity for regulatory T cells relevant to targeting follicular lymphoma?","Among the genes POLR3GL, NDUFA8, MAG, TNFAIP1, and GATA6, which exhibits the highest specificity for regulatory T cells relevant to targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Then, determine which of these targets overlap with PINNACLE's set of regulatory T cell–activated genes to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping targets and calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA10', 'POMP', 'CHSY1', 'THAP4', 'CENPK']",follicular lymphoma,regulatory t cell,NDUFA10,"Which gene among NDUFA10, POMP, CHSY1, THAP4, and CENPK exhibits the most cell-type-specific expression in regulatory T cells, making it the optimal candidate for targeted therapy in follicular lymphoma?","Which gene among NDUFA10, POMP, CHSY1, THAP4, and CENPK exhibits the most cell-type-specific expression in regulatory T cells, making it the optimal candidate for targeted therapy in follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which regulatory T cell-activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CDX2', 'CFAP161', 'APPL2', 'CD38', 'AFF2']",follicular lymphoma,regulatory t cell,CD38,"Which gene among CDX2, CFAP161, APPL2, CD38, and AFF2 exhibits the highest specificity in regulatory T cells, thereby representing the most promising candidate for targeting follicular lymphoma?","Which gene among CDX2, CFAP161, APPL2, CD38, and AFF2 exhibits the highest specificity in regulatory T cells, thereby representing the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets to define a set of cell-type–specific candidates. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['AGAP2', 'MOXD1', 'SLC22A18', 'NDUFB9', 'CPN2']",follicular lymphoma,regulatory t cell,NDUFB9,"Which gene among AGAP2, MOXD1, SLC22A18, NDUFB9, and CPN2 shows the most selective expression in regulatory T cells, making it a prime candidate for targeted therapy in follicular lymphoma?","Which gene among AGAP2, MOXD1, SLC22A18, NDUFB9, and CPN2 shows the most selective expression in regulatory T cells, making it a prime candidate for targeted therapy in follicular lymphoma? Which validated therapeutic targets for follicular lymphoma have cell-type–specific embeddings available in PINNACLE, and how do they overlap with regulatory T cell-activated genes? Retrieve the embeddings for these targets from PINNACLE, identify the overlapping set with Treg-activated genes, and compute the average embedding vector for this subset. Next, calculate the cosine similarity between each individual target's embedding and the average reference vector. If a single gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['GABRB1', 'GTPBP8', 'IRF3', 'TMEM258', 'TNFRSF4']",follicular lymphoma,regulatory t cell,TNFRSF4,"Among the genes GABRB1, GTPBP8, IRF3, TMEM258, and TNFRSF4, which shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma?","Among the genes GABRB1, GTPBP8, IRF3, TMEM258, and TNFRSF4, which shows the highest cell-type specificity in regulatory T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets are activated by regulatory T cells in PINNACLE. For the overlapping set, compute their average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CLEC18A', 'EGFLAM', 'NDUFB4', 'TEX28', 'TUBGCP4']",follicular lymphoma,regulatory t cell,NDUFB4,"Which gene among CLEC18A, EGFLAM, NDUFB4, TEX28, and TUBGCP4 exhibits the most specific expression in regulatory T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among CLEC18A, EGFLAM, NDUFB4, TEX28, and TUBGCP4 exhibits the most specific expression in regulatory T cells, making it the optimal candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which regulatory T cell–activated genes in PINNACLE overlap with these targets. Compute the average embedding for this overlapping gene set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ANKS1A', 'CKLF', 'MCL1', 'DCAF12', 'TRPC6']",follicular lymphoma,regulatory t cell,MCL1,"Which gene among ANKS1A, CKLF, MCL1, DCAF12, and TRPC6 exhibits the highest specificity for regulatory T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among ANKS1A, CKLF, MCL1, DCAF12, and TRPC6 exhibits the highest specificity for regulatory T cells, making it the most promising candidate for targeting follicular lymphoma? Identify and retrieve the cell-type–specific embeddings for verified therapeutic targets of follicular lymphoma from PINNACLE. Next, determine the overlap between these targets and the regulatory T cell–activated genes in PINNACLE to define the follicular lymphoma-specific target set. Compute the average embedding of this set as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GRK4', 'GOLGA6L9', 'TXNRD1', 'DIP2B', 'POLD4']",follicular lymphoma,regulatory t cell,POLD4,"Among GRK4, GOLGA6L9, TXNRD1, DIP2B, and POLD4, which gene exhibits the greatest specificity for regulatory T cells, thereby serving as the most promising candidate target for follicular lymphoma?","Among GRK4, GOLGA6L9, TXNRD1, DIP2B, and POLD4, which gene exhibits the greatest specificity for regulatory T cells, thereby serving as the most promising candidate target for follicular lymphoma? Using PINNACLE, identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and the regulatory T cell‐activated genes available in PINNACLE to define a set of cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set as a reference, and then compute the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LRRC23', 'PSMD1', 'PTPRC', 'MBD1', 'NDUFA12']",follicular lymphoma,regulatory t cell,NDUFA12,"Among the genes LRRC23, PSMD1, PTPRC, MBD1, and NDUFA12, which one exhibits the highest cell-type specificity within regulatory T cells for targeting follicular lymphoma?","Among the genes LRRC23, PSMD1, PTPRC, MBD1, and NDUFA12, which one exhibits the highest cell-type specificity within regulatory T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes activated in regulatory T cells in PINNACLE, yielding the candidate cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this average and each individual target’s embedding. Finally, if one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['MAGI3', 'CDK4', 'COTL1P1', 'EFNB2', 'TSGA10']",follicular lymphoma,regulatory t cell,CDK4,"Which gene among MAGI3, CDK4, COTL1P1, EFNB2, and TSGA10 exhibits the most specific expression in regulatory T cells relevant to targeting follicular lymphoma?","Which gene among MAGI3, CDK4, COTL1P1, EFNB2, and TSGA10 exhibits the most specific expression in regulatory T cells relevant to targeting follicular lymphoma? Identify the established therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which genes activated in regulatory T cells overlap with these targets, and compute the average embedding of this overlapping set as a reference. Then, calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DSCR8', 'NDUFS3', 'RHBDL2', 'UPF1', 'PLS3']",follicular lymphoma,regulatory t cell,NDUFS3,"Among the genes DSCR8, NDUFS3, RHBDL2, UPF1, and PLS3, which one exhibits the highest cell-type specificity in regulatory T cells for follicular lymphoma targeting?","Among the genes DSCR8, NDUFS3, RHBDL2, UPF1, and PLS3, which one exhibits the highest cell-type specificity in regulatory T cells for follicular lymphoma targeting? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Then, determine which regulatory T cell-activated genes in PINNACLE overlap with these targets to define a set of cell-type-specific targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target's embedding. If one gene displays markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA7', 'HRH2', 'KRTAP3-4P', 'TRAPPC2B', 'AP3B1']",follicular lymphoma,regulatory t cell,NDUFA7,"Among the genes NDUFA7, HRH2, KRTAP3-4P, TRAPPC2B, and AP3B1, which one exhibits the highest specificity of expression in regulatory T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes NDUFA7, HRH2, KRTAP3-4P, TRAPPC2B, and AP3B1, which one exhibits the highest specificity of expression in regulatory T cells, making it the most promising candidate for targeting follicular lymphoma? For follicular lymphoma, identify the validated therapeutic targets and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the regulatory T cell-activated genes within PINNACLE intersect with these targets, forming the set of cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['THUMPD3', 'LRP2', 'ITGAD', 'GDF5-AS1', 'NDUFB7']",follicular lymphoma,regulatory t cell,NDUFB7,"Which gene among THUMPD3, LRP2, ITGAD, GDF5-AS1, and NDUFB7 exhibits the highest cell-type specificity in regulatory T cells relevant to targeting follicular lymphoma?","Which gene among THUMPD3, LRP2, ITGAD, GDF5-AS1, and NDUFB7 exhibits the highest cell-type specificity in regulatory T cells relevant to targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with regulatory T cell–activated genes from PINNACLE to define a set of cell-type–specific targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual gene embedding. If one gene exhibits a notably higher similarity than the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZNF786', 'ZSCAN29', 'FGR', 'PCBD1', 'RFPL3']",follicular lymphoma,exhausted t cell,FGR,"Which gene (ZNF786, ZSCAN29, FGR, PCBD1, or RFPL3) exhibits the highest cell-type specificity in exhausted T cells, making it the optimal candidate target for follicular lymphoma?","Which gene (ZNF786, ZSCAN29, FGR, PCBD1, or RFPL3) exhibits the highest cell-type specificity in exhausted T cells, making it the optimal candidate target for follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes among the exhausted T cell-activated set in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference vector and each individual target’s embedding. Finally, if one gene displays substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GKN2', 'NDUFAF4', 'GZF1', 'ODAPH', 'TOX']",follicular lymphoma,exhausted t cell,NDUFAF4,"Which gene, among GKN2, NDUFAF4, GZF1, ODAPH, and TOX, exhibits the highest cell-type specificity in exhausted T cells as a potential target for follicular lymphoma therapy?","Which gene, among GKN2, NDUFAF4, GZF1, ODAPH, and TOX, exhibits the highest cell-type specificity in exhausted T cells as a potential target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which of the genes associated with exhausted T cell activation in PINNACLE overlap with these targets to define cell-type-specific targets for follicular lymphoma. Compute the average embedding for this overlapping gene set as a reference, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['UBTD2', 'SUCLG1', 'CPOX', 'PIK3R1', 'FCRL5']",follicular lymphoma,exhausted t cell,PIK3R1,"Which gene among UBTD2, SUCLG1, CPOX, PIK3R1, and FCRL5 exhibits the highest cell-type specificity in exhausted T cells, making it the optimal candidate for targeting follicular lymphoma?","Which gene among UBTD2, SUCLG1, CPOX, PIK3R1, and FCRL5 exhibits the highest cell-type specificity in exhausted T cells, making it the optimal candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes associated with exhausted, activated T cells in PINNACLE. Calculate the average embedding of this overlapping set as a reference and then compute the cosine similarity between this reference and the embedding of each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC8', 'MAGEA1', 'KRTAP5-9', 'CDK17', 'TTBK2']",follicular lymphoma,exhausted t cell,HDAC8,"Among the genes HDAC8, MAGEA1, KRTAP5-9, CDK17, and TTBK2, which one exhibits the highest cell-type specificity in exhausted T cells for follicular lymphoma?","Among the genes HDAC8, MAGEA1, KRTAP5-9, CDK17, and TTBK2, which one exhibits the highest cell-type specificity in exhausted T cells for follicular lymphoma? Using PINNACLE, first identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, determine which genes among the exhausted T cell–activated set overlap with these targets to define your candidate therapeutic targets. Calculate the average embedding for this candidate set, then compute the cosine similarity between this average and each gene’s embedding. If one gene exhibits a significantly higher similarity, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['RUFY2', 'TRAF5', 'NDUFS3', 'SEPTIN11', 'HEXD']",follicular lymphoma,exhausted t cell,NDUFS3,"Among the genes RUFY2, TRAF5, NDUFS3, SEPTIN11, and HEXD, which one exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma?","Among the genes RUFY2, TRAF5, NDUFS3, SEPTIN11, and HEXD, which one exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the set of exhausted T cell–activated genes in PINNACLE to define the cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['CDK4', 'TNP2', 'L1TD1', 'WDR91', 'SOST']",follicular lymphoma,exhausted t cell,CDK4,"Among the genes CDK4, TNP2, L1TD1, WDR91, and SOST, which one demonstrates the highest cell-type specificity in exhausted T cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Among the genes CDK4, TNP2, L1TD1, WDR91, and SOST, which one demonstrates the highest cell-type specificity in exhausted T cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which exhausted T cell activation genes in PINNACLE overlap with these targets to form a set of cell-type–specific follicular lymphoma targets. Compute the average embedding for this gene set, then calculate the cosine similarity between the average and each individual gene's embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS7', 'AP2B1', 'CXCL8', 'C20orf85', 'ADCY9']",follicular lymphoma,exhausted t cell,NDUFS7,"Which gene among NDUFS7, AP2B1, CXCL8, C20orf85, and ADCY9 exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma?","Which gene among NDUFS7, AP2B1, CXCL8, C20orf85, and ADCY9 exhibits the highest cell-type specificity in exhausted T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, identify the overlap between these targets and the set of exhausted T cell–activated genes in PINNACLE to define candidate cell-type–specific targets. Compute the average embedding for this candidate set and calculate the cosine similarity between this reference and each individual gene embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFAF3', 'TOLLIP', 'CCDC157', 'GMCL1', 'KRTCAP2']",follicular lymphoma,exhausted t cell,NDUFAF3,"Which gene among NDUFAF3, TOLLIP, CCDC157, GMCL1, and KRTCAP2 demonstrates the highest cell-type-specific expression in exhausted T cells, making it the most promising target for follicular lymphoma therapy?","Which gene among NDUFAF3, TOLLIP, CCDC157, GMCL1, and KRTCAP2 demonstrates the highest cell-type-specific expression in exhausted T cells, making it the most promising target for follicular lymphoma therapy? Retrieve the cell-type–specific embeddings from PINNACLE for all verified therapeutic targets associated with follicular lymphoma. Next, identify the subset of these targets that overlap with the exhausted T cell–activated genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PLSCR2', 'NDUFB9', 'PIGS', 'ERI1', 'RTP2']",follicular lymphoma,exhausted t cell,NDUFB9,"Which gene among PLSCR2, NDUFB9, PIGS, ERI1, and RTP2 exhibits the highest cell-type specificity in exhausted T cells for targeted intervention in follicular lymphoma?","Which gene among PLSCR2, NDUFB9, PIGS, ERI1, and RTP2 exhibits the highest cell-type specificity in exhausted T cells for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the exhausted T cell-activated genes in PINNACLE. For the overlapping genes, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['SLC30A7', 'SH3GL2', 'CPXM2', 'TLR7', 'NDUFS2']",follicular lymphoma,exhausted t cell,NDUFS2,"Among the genes SLC30A7, SH3GL2, CPXM2, TLR7, and NDUFS2, which one shows the highest cell-type specificity in exhausted T cells for potential targeting in follicular lymphoma?","Among the genes SLC30A7, SH3GL2, CPXM2, TLR7, and NDUFS2, which one shows the highest cell-type specificity in exhausted T cells for potential targeting in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, find the overlap between these targets and the exhausted T cell-activated genes in PINNACLE. For the overlapping targets, compute the average embedding and determine the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DPH3', 'NDUFS5', 'PC', 'SETD1A', 'HOXD12']",follicular lymphoma,exhausted t cell,NDUFS5,"Which gene—DPH3, NDUFS5, PC, SETD1A, or HOXD12—exhibits the highest specificity in exhausted T cells for potential targeting in follicular lymphoma?","Which gene—DPH3, NDUFS5, PC, SETD1A, or HOXD12—exhibits the highest specificity in exhausted T cells for potential targeting in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and the exhausted T cell-activated genes in PINNACLE. Calculate the average embedding for the overlapping set, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MCHR1', 'CCDC127', 'FGD2', 'NDUFB4', 'ANKRD13C']",follicular lymphoma,exhausted t cell,NDUFB4,"Which gene among MCHR1, CCDC127, FGD2, NDUFB4, and ANKRD13C exhibits the highest specificity in exhausted T cells, making it the most suitable candidate for targeted therapy in follicular lymphoma?","Which gene among MCHR1, CCDC127, FGD2, NDUFB4, and ANKRD13C exhibits the highest specificity in exhausted T cells, making it the most suitable candidate for targeted therapy in follicular lymphoma? Identify established therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes among the exhausted T cell activation markers in PINNACLE overlap with these targets, as these represent the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set to serve as a reference, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['UGT1A8', 'MT-CO1', 'RBX1', 'SLC1A6', 'ASTE1']",follicular lymphoma,exhausted t cell,RBX1,"Among the genes UGT1A8, MT-CO1, RBX1, SLC1A6, and ASTE1, which one shows the highest specificity for exhausted T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Among the genes UGT1A8, MT-CO1, RBX1, SLC1A6, and ASTE1, which one shows the highest specificity for exhausted T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the set of activated exhausted T cell genes available in PINNACLE. Compute the average embedding for this overlapping group and calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA3', 'TTC13', 'KLHL9', 'UBE2M', 'KLHL22']",follicular lymphoma,exhausted t cell,NDUFA3,"Among NDUFA3, TTC13, KLHL9, UBE2M, and KLHL22, which gene exhibits the highest specificity for exhausted T cells in the context of targeting follicular lymphoma?","Among NDUFA3, TTC13, KLHL9, UBE2M, and KLHL22, which gene exhibits the highest specificity for exhausted T cells in the context of targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which PINNACLE-defined exhausted T cell-activated genes overlap with these targets, thereby delineating the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of the overlapping genes to serve as a reference, and then compute the cosine similarity between this reference and each individual target’s embedding. If one gene exhibits notably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['YPEL2', 'BBS2', 'ADAM9', 'GIMAP1', 'PPIA']",follicular lymphoma,exhausted t cell,PPIA,"Which gene among YPEL2, BBS2, ADAM9, GIMAP1, and PPIA exhibits the highest specificity in exhausted T cells, thereby serving as the most promising candidate for targeted follicular lymphoma therapy?","Which gene among YPEL2, BBS2, ADAM9, GIMAP1, and PPIA exhibits the highest specificity in exhausted T cells, thereby serving as the most promising candidate for targeted follicular lymphoma therapy? Using the PINNACLE dataset, identify validated therapeutic targets for follicular lymphoma by retrieving their cell-type–specific embeddings. Next, determine which of these targets overlap with the set of exhausted T cell-activated genes in PINNACLE to define a subset of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this subset as a reference, then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CTSB', 'PMS2', 'ARHGAP9', 'SDHB', 'NR3C1']",follicular lymphoma,exhausted t cell,NR3C1,"Which gene among CTSB, PMS2, ARHGAP9, SDHB, and NR3C1 exhibits the highest specificity for exhausted T cells, making it the most promising candidate for targeted intervention in follicular lymphoma?","Which gene among CTSB, PMS2, ARHGAP9, SDHB, and NR3C1 exhibits the highest specificity for exhausted T cells, making it the most promising candidate for targeted intervention in follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which exhausted T cell-activated genes in PINNACLE intersect with these targets to form a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of these genes as a reference, and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['BTBD8', 'PSMB5', 'ZNF337', 'KIAA0825', 'TREX2']",follicular lymphoma,exhausted t cell,PSMB5,"Which gene among BTBD8, PSMB5, ZNF337, KIAA0825, and TREX2 exhibits the highest specificity for exhausted T cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among BTBD8, PSMB5, ZNF337, KIAA0825, and TREX2 exhibits the highest specificity for exhausted T cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which exhausted T cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this subset, then calculate the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MYH15', 'NDUFB10', 'ING2', 'ZNF251', 'TMC6']",follicular lymphoma,exhausted t cell,NDUFB10,"Which gene among MYH15, NDUFB10, ING2, ZNF251, and TMC6 exhibits the highest expression specificity in exhausted T cells, making it the most suitable target for follicular lymphoma treatment?","Which gene among MYH15, NDUFB10, ING2, ZNF251, and TMC6 exhibits the highest expression specificity in exhausted T cells, making it the most suitable target for follicular lymphoma treatment? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which genes among the exhausted T cell activation markers in PINNACLE overlap with these targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between the average embedding and each individual target’s embedding. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NKAPD1', 'CD3E', 'FAM110C', 'BARHL2', 'RHO']",follicular lymphoma,exhausted t cell,CD3E,"Among the genes NKAPD1, CD3E, FAM110C, BARHL2, and RHO, which one exhibits the highest cell-type specificity in exhausted T cells relevant for targeting follicular lymphoma?","Among the genes NKAPD1, CD3E, FAM110C, BARHL2, and RHO, which one exhibits the highest cell-type specificity in exhausted T cells relevant for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine which exhausted T cell-activated genes in PINNACLE intersect with these targets, as this set represents the cell-type-specific targets for follicular lymphoma. Calculate the average embedding of this intersecting set to serve as a reference, then compute the cosine similarity between this reference embedding and each individual target's embedding. If one gene exhibits a markedly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological significance."
"['MBNL1', 'KAT8', 'RRAGA', 'NDUFC2', 'SREBF2']",follicular lymphoma,exhausted t cell,NDUFC2,"Among the genes MBNL1, KAT8, RRAGA, NDUFC2, and SREBF2, which one exhibits the highest cell-type specificity within exhausted T cells for targeting follicular lymphoma?","Among the genes MBNL1, KAT8, RRAGA, NDUFC2, and SREBF2, which one exhibits the highest cell-type specificity within exhausted T cells for targeting follicular lymphoma? Identify and retrieve the validated therapeutic targets for follicular lymphoma along with their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping genes between these targets and the exhausted T cell–activated genes in PINNACLE. For this overlap set, compute the average embedding as a reference and determine the cosine similarity of each gene’s embedding relative to this reference. If one gene exhibits a markedly higher similarity compared to the others, nominate it as the lead candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DIXDC1', 'FIGNL1', 'REM2', 'BCL2A1', 'HOMER1']",follicular lymphoma,t cell,BCL2A1,"Which gene among DIXDC1, FIGNL1, REM2, BCL2A1, and HOMER1 exhibits the highest T cell specificity for targeted follicular lymphoma therapy?","Which gene among DIXDC1, FIGNL1, REM2, BCL2A1, and HOMER1 exhibits the highest T cell specificity for targeted follicular lymphoma therapy? Using PINNACLE, extract the cell-type-specific embeddings for the verified therapeutic targets of follicular lymphoma. Next, identify the T cell–activated genes within PINNACLE that overlap with these targets, thereby defining the follicular lymphoma–specific targets. Compute the average embedding for this overlapping set as a reference point, and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['JAK1', 'PACSIN3', 'THAP8', 'AACS', 'IFNA8']",follicular lymphoma,t cell,JAK1,"Among JAK1, PACSIN3, THAP8, AACS, and IFNA8, which gene exhibits the highest T cell-specific expression and would be the most promising candidate for targeted follicular lymphoma interventions?","Among JAK1, PACSIN3, THAP8, AACS, and IFNA8, which gene exhibits the highest T cell-specific expression and would be the most promising candidate for targeted follicular lymphoma interventions? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the t cell–activated genes available in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average embedding and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PNISR', 'P4HB', 'NDUFV3', 'FEM1C', 'CDH16']",follicular lymphoma,t cell,NDUFV3,"Which gene among PNISR, P4HB, NDUFV3, FEM1C, and CDH16 exhibits the highest T-cell specificity for targeting follicular lymphoma?","Which gene among PNISR, P4HB, NDUFV3, FEM1C, and CDH16 exhibits the highest T-cell specificity for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which T cell–activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for this lymphoma. Compute the average embedding for this set and calculate the cosine similarity between the average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['PGLS', 'IFI16', 'DYRK1A', 'FAM187A', 'NDUFA4']",follicular lymphoma,t cell,NDUFA4,"Of the genes PGLS, IFI16, DYRK1A, FAM187A, and NDUFA4, which one exhibits the highest T cell-specific expression, making it the optimal candidate for targeted interventions in follicular lymphoma?","Of the genes PGLS, IFI16, DYRK1A, FAM187A, and NDUFA4, which one exhibits the highest T cell-specific expression, making it the optimal candidate for targeted interventions in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which t cell-activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for these overlapping targets and compute the cosine similarity between this reference embedding and each individual target. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MUC16', 'CTNS', 'CYGB', 'ZNF493', 'TNFRSF4']",follicular lymphoma,t cell,TNFRSF4,"Which gene among MUC16, CTNS, CYGB, ZNF493, and TNFRSF4 exhibits the highest T cell specificity, thereby representing the most suitable candidate for targeted therapy in follicular lymphoma?","Which gene among MUC16, CTNS, CYGB, ZNF493, and TNFRSF4 exhibits the highest T cell specificity, thereby representing the most suitable candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma in PINNACLE and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and the T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SOST', 'OR4C12', 'PDCD1', 'PPM1B', 'NOL10']",follicular lymphoma,t cell,PDCD1,"Among the genes SOST, OR4C12, PDCD1, PPM1B, and NOL10, which one exhibits the highest specificity for T cells, making it the most promising target for follicular lymphoma therapy?","Among the genes SOST, OR4C12, PDCD1, PPM1B, and NOL10, which one exhibits the highest specificity for T cells, making it the most promising target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. From the set of T cell–activated genes in PINNACLE, determine those that overlap with the therapeutic targets to define the cell-type–specific target set. Calculate the average embedding for this set and then compute the cosine similarity between this reference vector and each individual target’s embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRMT8', 'NPTN', 'PSMB5', 'TRAIP', 'SNUPN']",follicular lymphoma,t cell,PSMB5,"Which gene among PRMT8, NPTN, PSMB5, TRAIP, and SNUPN exhibits the highest specificity in T cells for potential therapeutic targeting of follicular lymphoma?","Which gene among PRMT8, NPTN, PSMB5, TRAIP, and SNUPN exhibits the highest specificity in T cells for potential therapeutic targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which T cell-activated genes from PINNACLE are also among these targets. For the overlapping set, compute the average embedding and calculate the cosine similarity between this reference embedding and each individual gene embedding. If one gene shows substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PARPBP', 'NDUFA9', 'JTB', 'CNFN', 'MAP7']",follicular lymphoma,t cell,NDUFA9,"Among the genes PARPBP, NDUFA9, JTB, CNFN, and MAP7, which one exhibits the highest specificity to T cells as a potential target in follicular lymphoma?","Among the genes PARPBP, NDUFA9, JTB, CNFN, and MAP7, which one exhibits the highest specificity to T cells as a potential target in follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which T cell–activated genes in PINNACLE overlap with these targets to define the follicular lymphoma-specific target set. Compute the average embedding of this group and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KRT2', 'CCDC102B', 'DENND1A', 'DDX56', 'IMPDH1']",follicular lymphoma,t cell,IMPDH1,"Among the genes KRT2, CCDC102B, DENND1A, DDX56, and IMPDH1, which one exhibits the most T cell-specific expression, making it the most promising candidate for therapeutic targeting in follicular lymphoma?","Among the genes KRT2, CCDC102B, DENND1A, DDX56, and IMPDH1, which one exhibits the most T cell-specific expression, making it the most promising candidate for therapeutic targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE resource. Next, determine which T cell-activated genes in PINNACLE overlap with these therapeutic targets, defining them as the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between the average and each individual target embedding. If one gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TMEM167B', 'NUB1', 'ATP1B4', 'TIPIN', 'PRIM2']",follicular lymphoma,t cell,PRIM2,"Which gene among TMEM167B, NUB1, ATP1B4, TIPIN, and PRIM2 exhibits the highest T cell-specific expression relevant for targeting follicular lymphoma?","Which gene among TMEM167B, NUB1, ATP1B4, TIPIN, and PRIM2 exhibits the highest T cell-specific expression relevant for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the T cell-activated genes in PINNACLE to define the follicular lymphoma cell-type–specific targets. Compute the average embedding for this set as a reference, then calculate the cosine similarity between the reference and each individual target embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BARHL1', 'HDAC3', 'SLC38A4', 'DEFB105A', 'SPDYE2B']",follicular lymphoma,t cell,HDAC3,"Which gene among BARHL1, HDAC3, SLC38A4, DEFB105A, SPDYE2B exhibits the highest cell-type specificity in T cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among BARHL1, HDAC3, SLC38A4, DEFB105A, SPDYE2B exhibits the highest cell-type specificity in T cells, making it the most promising candidate for targeting follicular lymphoma? Identify all experimentally validated therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the set of T cell-activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the mean embedding of this overlapping gene set and compute the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFA12', 'C14orf180', 'ZNF354A', 'PPIL4', 'HSDL2']",follicular lymphoma,t cell,NDUFA12,"Among the genes NDUFA12, C14orf180, ZNF354A, PPIL4, and HSDL2, which one demonstrates the highest specificity in T cells that could make it the most promising target for follicular lymphoma treatment?","Among the genes NDUFA12, C14orf180, ZNF354A, PPIL4, and HSDL2, which one demonstrates the highest specificity in T cells that could make it the most promising target for follicular lymphoma treatment? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the genes activated in T cells according to PINNACLE. For the overlapping set, compute the average embedding to serve as a reference and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['LAG3', 'KLK7', 'MAGEB4', 'CARD6', 'CYB5D2']",follicular lymphoma,t cell,LAG3,"Which gene among LAG3, KLK7, MAGEB4, CARD6, and CYB5D2 exhibits the highest T-cell expression specificity relevant for targeting follicular lymphoma?","Which gene among LAG3, KLK7, MAGEB4, CARD6, and CYB5D2 exhibits the highest T-cell expression specificity relevant for targeting follicular lymphoma? Using the PINNACLE database, identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings. Then, determine the overlap between these targets and the T cell-activated gene set in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['MGAM', 'EEF1A1', 'MMP7', 'NDUFA6', 'HMGCR']",follicular lymphoma,t cell,NDUFA6,"Which gene among MGAM, EEF1A1, MMP7, NDUFA6, and HMGCR exhibits the highest T cell–specific expression suitable for targeting follicular lymphoma?","Which gene among MGAM, EEF1A1, MMP7, NDUFA6, and HMGCR exhibits the highest T cell–specific expression suitable for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from PINNACLE. Next, determine which targets overlap with the set of T cell-activated genes in PINNACLE to define the cell-type-specific targets for this lymphoma subtype. Compute the average embedding of these overlapping targets, then calculate the cosine similarity between this reference embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HSP90AB1', 'ST3GAL5', 'IL1RL1', 'ZBTB12', 'GABRA3']",follicular lymphoma,t cell,HSP90AB1,"Which gene among HSP90AB1, ST3GAL5, IL1RL1, ZBTB12, and GABRA3 demonstrates the most T cell–specific expression and thereby represents the best candidate for targeted follicular lymphoma therapy?","Which gene among HSP90AB1, ST3GAL5, IL1RL1, ZBTB12, and GABRA3 demonstrates the most T cell–specific expression and thereby represents the best candidate for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the T cell–activated genes available in PINNACLE to define the cell-type–specific targets for this disease. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene clearly exhibits a significantly higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological importance in follicular lymphoma."
"['BRWD1', 'GOLGA6L9', 'BAG4', 'RRM1', 'HCN3']",follicular lymphoma,t cell,RRM1,"Which gene among BRWD1, GOLGA6L9, BAG4, RRM1, and HCN3 exhibits the highest T-cell specificity, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among BRWD1, GOLGA6L9, BAG4, RRM1, and HCN3 exhibits the highest T-cell specificity, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which t cell-activated genes in PINNACLE overlap with these targets, forming a subset of cell-type–specific candidates. Compute the average embedding of this subset as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FBLN2', 'NDUFS6', 'UXS1', 'CCDC42', 'PML']",follicular lymphoma,t cell,NDUFS6,"Which gene among FBLN2, NDUFS6, UXS1, CCDC42, and PML exhibits the highest T cell-specific expression, making it the most promising candidate for targeted follicular lymphoma therapy?","Which gene among FBLN2, NDUFS6, UXS1, CCDC42, and PML exhibits the highest T cell-specific expression, making it the most promising candidate for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with PINNACLE’s set of T cell–activated genes to define the cell-type–specific targets. Compute the average embedding of these overlapping genes to create a reference vector, and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a clearly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['LENG8', 'CDK9', 'SOCS3', 'MAP4K5', 'ABCF2']",follicular lymphoma,t cell,CDK9,"Among the genes LENG8, CDK9, SOCS3, MAP4K5, and ABCF2, which one demonstrates the highest T cell-specific expression, making it the most promising target for follicular lymphoma therapy?","Among the genes LENG8, CDK9, SOCS3, MAP4K5, and ABCF2, which one demonstrates the highest T cell-specific expression, making it the most promising target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which T cell–activated genes in PINNACLE overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and then compute the cosine similarity between each individual target's embedding and the average embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EGLN2', 'CLEC10A', 'PEBP1', 'AHCTF1', 'TUBB4B']",follicular lymphoma,t cell,TUBB4B,"Which gene among EGLN2, CLEC10A, PEBP1, AHCTF1, and TUBB4B demonstrates the highest T-cell specificity in the context of targeting follicular lymphoma?","Which gene among EGLN2, CLEC10A, PEBP1, AHCTF1, and TUBB4B demonstrates the highest T-cell specificity in the context of targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the t cell-activated genes in PINNACLE to generate a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DHX58', 'NDUFAF3', 'USH1C', 'KRR1', 'SOX4']",follicular lymphoma,t cell,NDUFAF3,"Which gene among DHX58, NDUFAF3, USH1C, KRR1, and SOX4 exhibits the highest T cell-specific expression pattern, making it the most suitable candidate for targeted therapeutic intervention in follicular lymphoma?","Which gene among DHX58, NDUFAF3, USH1C, KRR1, and SOX4 exhibits the highest T cell-specific expression pattern, making it the most suitable candidate for targeted therapeutic intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the T cell–activated genes in PINNACLE. For the overlapping genes, compute their average embedding to serve as a reference and then calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SCGB3A1', 'FGR', 'DBNL', 'IGLV3-25', 'SLC25A23']",follicular lymphoma,mature nk t cell,FGR,"Among the genes SCGB3A1, FGR, DBNL, IGLV3-25, and SLC25A23, which one exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma?","Among the genes SCGB3A1, FGR, DBNL, IGLV3-25, and SLC25A23, which one exhibits the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the mature NK/T cell-activated genes in PINNACLE to define a set of follicular lymphoma–relevant targets. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this reference embedding and each individual target. If a single gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CEMIP2', 'C4orf33', 'DDB1', 'MAP7D1', 'DOCK6']",follicular lymphoma,mature nk t cell,DDB1,"Among the genes CEMIP2, C4orf33, DDB1, MAP7D1, and DOCK6, which one exhibits the highest specificity of expression in mature natural killer T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes CEMIP2, C4orf33, DDB1, MAP7D1, and DOCK6, which one exhibits the highest specificity of expression in mature natural killer T cells, making it the most promising candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the genes activated in mature NK T cells within PINNACLE. Calculate the average embedding for this overlapping set as a reference and compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['MT-ND3', 'HK2', 'FAM160A1', 'SDCCAG8', 'SF3B2']",follicular lymphoma,mature nk t cell,MT-ND3,"Among the genes MT-ND3, HK2, FAM160A1, SDCCAG8, and SF3B2, which one exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Among the genes MT-ND3, HK2, FAM160A1, SDCCAG8, and SF3B2, which one exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify all validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the mature NK T cell-activated genes available in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping targets, then calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['SURF4', 'SPATA3', 'BCL2A1', 'LUC7L3', 'SPRYD7']",follicular lymphoma,mature nk t cell,BCL2A1,"Which gene among SURF4, SPATA3, BCL2A1, LUC7L3, and SPRYD7 displays the highest cell-type specificity in mature natural killer T cells for potential targeting of follicular lymphoma?","Which gene among SURF4, SPATA3, BCL2A1, LUC7L3, and SPRYD7 displays the highest cell-type specificity in mature natural killer T cells for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type‑specific embedding profiles from the PINNACLE dataset. Next, identify the intersection of these targets with genes activated in mature NK T cells within PINNACLE. Compute the average embedding for the overlapping genes and calculate the cosine similarity between this average reference and each individual gene embedding. If one gene exhibits a significantly higher similarity compared to the others, designate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TMEM43', 'MCTS1', 'KDM3B', 'SIK3', 'MCL1']",follicular lymphoma,mature nk t cell,MCL1,"Among TMEM43, MCTS1, KDM3B, SIK3, and MCL1, which gene exhibits the highest specificity for mature NK/T cells, thereby representing the most promising candidate for targeted intervention in follicular lymphoma?","Among TMEM43, MCTS1, KDM3B, SIK3, and MCL1, which gene exhibits the highest specificity for mature NK/T cells, thereby representing the most promising candidate for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which mature NK T cell–activated genes in PINNACLE overlap with these targets. Using the overlapping set as the candidate cell-type–specific targets, calculate their average embedding as a reference profile and compute the cosine similarity between this reference and each individual target. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CSN2', 'SLC35B1', 'NDUFB9', 'AQP8', 'ZDHHC17']",follicular lymphoma,mature nk t cell,NDUFB9,"Among the genes CSN2, SLC35B1, NDUFB9, AQP8, and ZDHHC17, which one exhibits the highest cell-type specificity in mature natural killer T cells, thereby representing the most promising target for follicular lymphoma?","Among the genes CSN2, SLC35B1, NDUFB9, AQP8, and ZDHHC17, which one exhibits the highest cell-type specificity in mature natural killer T cells, thereby representing the most promising target for follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Among the mature NK/T cell-activated genes in PINNACLE, determine which overlap with these therapeutic targets. For this overlapping set, compute the average embedding to serve as a reference, and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a distinctly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TELO2', 'PIK3CD', 'FAM76B', 'DMD', 'SLC35B1']",follicular lymphoma,mature nk t cell,PIK3CD,"Among TELO2, PIK3CD, FAM76B, DMD, and SLC35B1, which gene exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Among TELO2, PIK3CD, FAM76B, DMD, and SLC35B1, which gene exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with genes associated with mature natural killer T cell activation in PINNACLE. Calculate the average embedding of the overlapping genes, then compute the cosine similarity between this reference embedding and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PLAC9', 'FUT8', 'HABP4', 'CBLB', 'NDUFS4']",follicular lymphoma,mature nk t cell,NDUFS4,"Which gene among PLAC9, FUT8, HABP4, CBLB, and NDUFS4 exhibits the most restricted expression in mature natural killer T cells, thereby representing the optimal target for follicular lymphoma therapy?","Which gene among PLAC9, FUT8, HABP4, CBLB, and NDUFS4 exhibits the most restricted expression in mature natural killer T cells, thereby representing the optimal target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the intersection of these targets with the mature NK T cell activation gene set from PINNACLE. Compute the average embedding of the overlapping genes as a reference and calculate the cosine similarity between this reference and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological relevance."
"['AGAP3', 'PTTG2', 'TOP1', 'RABGEF1', 'SLC4A2']",follicular lymphoma,mature nk t cell,TOP1,"Which of the following genes—AGAP3, PTTG2, TOP1, RABGEF1, or SLC4A2—displays the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma?","Which of the following genes—AGAP3, PTTG2, TOP1, RABGEF1, or SLC4A2—displays the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma? Using PINNACLE data, identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings. Next, determine the overlap between these targets and the set of mature NK T cell–activated genes in PINNACLE to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of these overlapping genes as a reference point, and then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['SV2B', 'SAMD1', 'LMLN', 'SUMO2', 'NDUFB7']",follicular lymphoma,mature nk t cell,NDUFB7,"Among the genes SV2B, SAMD1, LMLN, SUMO2, and NDUFB7, which one exhibits the highest cell-type specificity in mature NK T cells and is the most promising candidate for targeting follicular lymphoma?","Among the genes SV2B, SAMD1, LMLN, SUMO2, and NDUFB7, which one exhibits the highest cell-type specificity in mature NK T cells and is the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which mature NK/T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding from this overlapping set and calculate the cosine similarity between this average reference and each individual target. If one gene exhibits a markedly higher similarity than the others, select it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MT-ND2', 'TMPRSS15', 'MR1', 'OR4F3', 'ACOT8']",follicular lymphoma,mature nk t cell,MT-ND2,"Which gene among MT-ND2, TMPRSS15, MR1, OR4F3, and ACOT8 shows the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma?","Which gene among MT-ND2, TMPRSS15, MR1, OR4F3, and ACOT8 shows the highest cell-type specificity in mature NK T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type specific embeddings from PINNACLE. Next, determine which genes activated in mature NK T cells in PINNACLE overlap with these targets. For this overlapping set, compute the average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological relevance."
"['GJA8', 'NDUFA6', 'TMEFF1', 'DDX19B', 'HORMAD2']",follicular lymphoma,mature nk t cell,NDUFA6,"Among the genes GJA8, NDUFA6, TMEFF1, DDX19B, and HORMAD2, which one shows the highest cell-type specificity in mature natural killer T cells, indicating its potential as the optimal target for follicular lymphoma therapy?","Among the genes GJA8, NDUFA6, TMEFF1, DDX19B, and HORMAD2, which one shows the highest cell-type specificity in mature natural killer T cells, indicating its potential as the optimal target for follicular lymphoma therapy? Identify verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the genes activated in mature NK T cells in PINNACLE; this overlapping set represents the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this set and then compute the cosine similarity between this average and each individual target. Finally, if one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['HSPB2', 'LGALS1', 'HDAC3', 'AQP6', 'LRIT1']",follicular lymphoma,mature nk t cell,HDAC3,"Among the genes HSPB2, LGALS1, HDAC3, AQP6, and LRIT1, which exhibits the most specific expression in mature natural killer T cells and is the most promising target for follicular lymphoma therapy?","Among the genes HSPB2, LGALS1, HDAC3, AQP6, and LRIT1, which exhibits the most specific expression in mature natural killer T cells and is the most promising target for follicular lymphoma therapy? Using PINNACLE, retrieve the cell-type–specific embeddings for verified therapeutic targets in follicular lymphoma. Identify those genes that also belong to the mature NK T cell-activated group in PINNACLE, thereby defining the cell-type–specific targets. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS5', 'F8A1', 'TMSB4XP2', 'ARF6', 'IRF2BPL']",follicular lymphoma,mature nk t cell,NDUFS5,"Which gene among NDUFS5, F8A1, TMSB4XP2, ARF6, and IRF2BPL exhibits the greatest cell-type specificity in mature natural killer T cells, making it the most promising target for follicular lymphoma therapy?","Which gene among NDUFS5, F8A1, TMSB4XP2, ARF6, and IRF2BPL exhibits the greatest cell-type specificity in mature natural killer T cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, identify the overlapping genes between these targets and the set of mature activated NK T-cell genes in PINNACLE. For the overlapping genes, calculate the average embedding as a reference and compute the cosine similarity between this reference and each target's embedding. If one gene shows a markedly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BCL9', 'MACC1', 'CD1E', 'NDUFS8', 'MIER1']",follicular lymphoma,mature nk t cell,NDUFS8,"Which gene among BCL9, MACC1, CD1E, NDUFS8, and MIER1 exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Which gene among BCL9, MACC1, CD1E, NDUFS8, and MIER1 exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the mature NK T cell-activated genes in PINNACLE to define a set of cell-type–specific candidates. Calculate the average embedding for this overlapping set, then compute the cosine similarity between this averaged vector and each individual candidate’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PIK3R1', 'HCRTR2', 'AAR2', 'PPP3R2', 'QRICH2']",follicular lymphoma,mature nk t cell,PIK3R1,"Among the genes PIK3R1, HCRTR2, AAR2, PPP3R2, and QRICH2, which exhibits the highest cell-type specificity in mature NK T cells, making it the most promising candidate for targeting follicular lymphoma?","Among the genes PIK3R1, HCRTR2, AAR2, PPP3R2, and QRICH2, which exhibits the highest cell-type specificity in mature NK T cells, making it the most promising candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Then, determine which mature NK T cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Calculate the average embedding for the overlapping genes and compute the cosine similarity between this average and each individual target embedding. If one gene exhibits a significantly higher cosine similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['TAF12', 'HLA-DRB5', 'CCDC57', 'HYOU1', 'SLC5A5']",follicular lymphoma,mature nk t cell,HLA-DRB5,"Among the genes TAF12, HLA-DRB5, CCDC57, HYOU1, and SLC5A5, which one shows the highest specificity in mature NK T cells for targeting follicular lymphoma?","Among the genes TAF12, HLA-DRB5, CCDC57, HYOU1, and SLC5A5, which one shows the highest specificity in mature NK T cells for targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of mature NK T cell-activated genes available in PINNACLE. Using the overlapping genes, compute an average embedding vector and then calculate the cosine similarity between this reference vector and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['LRRK1', 'RALGPS1', 'LRIT1', 'NDUFV1', 'CRMP1']",follicular lymphoma,mature nk t cell,NDUFV1,"Which gene among LRRK1, RALGPS1, LRIT1, NDUFV1, and CRMP1 exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma?","Which gene among LRRK1, RALGPS1, LRIT1, NDUFV1, and CRMP1 exhibits the highest cell-type specificity in mature natural killer T cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the mature NK T cell–activated genes in PINNACLE, as this overlapping set represents the potential cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set and calculate the cosine similarity between this reference and each individual target. If a single gene shows a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NMUR1', 'GGPS1', 'VPS37B', 'NDUFS7', 'FGF23']",follicular lymphoma,mature nk t cell,NDUFS7,"Among NMUR1, GGPS1, VPS37B, NDUFS7, and FGF23, which gene exhibits the highest cell-type specificity in mature natural killer T cells, making it the most promising target for follicular lymphoma therapy?","Among NMUR1, GGPS1, VPS37B, NDUFS7, and FGF23, which gene exhibits the highest cell-type specificity in mature natural killer T cells, making it the most promising target for follicular lymphoma therapy? Identify verified therapeutic targets for follicular lymphoma within the PINNACLE dataset and retrieve their cell-type–specific embeddings. Next, determine which of these overlap with genes associated with mature NK T cell activation to generate a subset of cell-type–specific targets. Calculate the average embedding of this subset and then compute the cosine similarity between each target's embedding and the reference average. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['DDX52', 'RASGRP3', 'KCND3', 'NCF1', 'POLE3']",follicular lymphoma,mature nk t cell,POLE3,"Which gene among DDX52, RASGRP3, KCND3, NCF1, and POLE3 exhibits the highest expression specificity in mature natural killer T cells for targeting follicular lymphoma?","Which gene among DDX52, RASGRP3, KCND3, NCF1, and POLE3 exhibits the highest expression specificity in mature natural killer T cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine the overlap between these targets and the set of mature NK T cell–activated genes in PINNACLE. For the intersecting genes, compute the average embedding to serve as a reference vector, and calculate the cosine similarity between this reference and each individual gene embedding. If one gene demonstrates a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological significance."
"['MIDN', 'KDM5B', 'TYK2', 'PLA2G1B', 'KRTAP9-8']",follicular lymphoma,myeloid cell,TYK2,"Which of the following genes—MIDN, KDM5B, TYK2, PLA2G1B, or KRTAP9-8—exhibits the highest specificity in myeloid cells for targeting follicular lymphoma?","Which of the following genes—MIDN, KDM5B, TYK2, PLA2G1B, or KRTAP9-8—exhibits the highest specificity in myeloid cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from the PINNACLE dataset. Next, determine which myeloid cell-activated genes in PINNACLE overlap with these targets, thereby defining a set of cell-type-specific therapeutic targets. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance in follicular lymphoma."
"['NEMP1', 'DIDO1', 'CRBN', 'DBP', 'SGSM1']",follicular lymphoma,myeloid cell,CRBN,"Which gene among NEMP1, DIDO1, CRBN, DBP, and SGSM1 exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma?","Which gene among NEMP1, DIDO1, CRBN, DBP, and SGSM1 exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which myeloid cell-activated genes in PINNACLE overlap with these targets to define the relevant cell-type–specific targets. Calculate the average embedding of this overlap set and compute the cosine similarity between this average and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['SLN', 'BTBD3', 'EPPK1', 'NR2F1', 'TOP1']",follicular lymphoma,myeloid cell,TOP1,"Among the genes SLN, BTBD3, EPPK1, NR2F1, and TOP1, which one exhibits the highest degree of myeloid cell-specific expression relevant to targeting follicular lymphoma?","Among the genes SLN, BTBD3, EPPK1, NR2F1, and TOP1, which one exhibits the highest degree of myeloid cell-specific expression relevant to targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with the myeloid cell-activated genes listed in PINNACLE. For this overlapping set, compute an average embedding to serve as a reference, then calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['RAB5B', 'PPFIA4', 'FBL', 'ODAD3', 'CDK4']",follicular lymphoma,myeloid cell,CDK4,"Among the candidate genes RAB5B, PPFIA4, FBL, ODAD3, and CDK4, which single gene exhibits the highest cell-type specificity in myeloid cells and stands out as the optimal target for follicular lymphoma therapy?","Among the candidate genes RAB5B, PPFIA4, FBL, ODAD3, and CDK4, which single gene exhibits the highest cell-type specificity in myeloid cells and stands out as the optimal target for follicular lymphoma therapy? Retrieve the cell-type–specific embeddings from PINNACLE for the verified therapeutic targets of follicular lymphoma, and identify which myeloid cell-activated genes in PINNACLE overlap with these targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between this reference and each individual gene's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['TAPBPL', 'IFNAR1', 'GSG1L', 'DUX4L1', 'TCEAL3']",follicular lymphoma,myeloid cell,IFNAR1,"Which gene among TAPBPL, IFNAR1, GSG1L, DUX4L1, and TCEAL3 exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma?","Which gene among TAPBPL, IFNAR1, GSG1L, DUX4L1, and TCEAL3 exhibits the highest cell-type specificity in myeloid cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, identify the overlap between these targets and the myeloid cell-activated genes in PINNACLE, defining the set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for these overlapping genes, then calculate the cosine similarity between this average reference and each individual gene embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['LAG3', 'GUCA2A', 'KIR2DL2', 'TSPAN1', 'ZNF264']",follicular lymphoma,myeloid cell,LAG3,"Among LAG3, GUCA2A, KIR2DL2, TSPAN1, and ZNF264, which gene demonstrates the highest specificity in myeloid cells for targeting follicular lymphoma?","Among LAG3, GUCA2A, KIR2DL2, TSPAN1, and ZNF264, which gene demonstrates the highest specificity in myeloid cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the myeloid cell-activated genes in PINNACLE to define the cell-type–specific targets for this lymphoma. Calculate the average embedding of this overlapping set as a reference, and then compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BMS1P1', 'CENPH', 'APOC2', 'NDUFA12', 'SLC25A35']",follicular lymphoma,myeloid cell,NDUFA12,"Among the genes BMS1P1, CENPH, APOC2, NDUFA12, and SLC25A35, which one exhibits the highest myeloid cell-type specificity for targeting follicular lymphoma?","Among the genes BMS1P1, CENPH, APOC2, NDUFA12, and SLC25A35, which one exhibits the highest myeloid cell-type specificity for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and myeloid cell-activated genes in PINNACLE. For the overlapping genes, compute the average embedding to serve as a reference profile and then calculate the cosine similarity between this reference and the embedding of each individual gene. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ZSCAN1', 'JAK3', 'MT1H', 'TACO1', 'COMMD8']",follicular lymphoma,myeloid cell,JAK3,"Which gene among ZSCAN1, JAK3, MT1H, TACO1, and COMMD8 exhibits the highest specificity for myeloid cells, making it the most suitable candidate for targeting follicular lymphoma?","Which gene among ZSCAN1, JAK3, MT1H, TACO1, and COMMD8 exhibits the highest specificity for myeloid cells, making it the most suitable candidate for targeting follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma that have cell-type–specific embeddings in PINNACLE. Determine which of these targets overlap with the myeloid cell-activated genes in PINNACLE, then compute the average embedding for this overlapping set and calculate the cosine similarity between this average and each individual target embedding. If one gene shows a markedly higher similarity compared to the rest, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['C19orf38', 'CKMT2', 'IFIT1', 'HDAC8', 'CLDN19']",follicular lymphoma,myeloid cell,HDAC8,"Among the genes C19orf38, CKMT2, IFIT1, HDAC8, and CLDN19, which one exhibits the highest specificity for myeloid cells as a potential target in follicular lymphoma?","Among the genes C19orf38, CKMT2, IFIT1, HDAC8, and CLDN19, which one exhibits the highest specificity for myeloid cells as a potential target in follicular lymphoma? Identify all validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with genes activated in myeloid cells, thereby defining the cell-type–specific targets. Calculate the average embedding for this overlapping set and compute the cosine similarity between the average embedding and each individual target. Finally, if one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['GM2A', 'UBE2Z', 'PAX8', 'ZNF419', 'NDUFB4']",follicular lymphoma,myeloid cell,NDUFB4,"Among the genes GM2A, UBE2Z, PAX8, ZNF419, and NDUFB4, which one exhibits the highest degree of cell-type specificity in myeloid cells as a candidate for targeted intervention in follicular lymphoma?","Among the genes GM2A, UBE2Z, PAX8, ZNF419, and NDUFB4, which one exhibits the highest degree of cell-type specificity in myeloid cells as a candidate for targeted intervention in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlapping genes between these targets and the set of myeloid cell-activated genes in PINNACLE to define cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this reference and each individual target gene. Finally, if one gene exhibits a markedly higher similarity than all others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['MT-ND1', 'CHML', 'FAM219B', 'TCHP', 'SERPINI2']",follicular lymphoma,myeloid cell,MT-ND1,"Among the genes MT-ND1, CHML, FAM219B, TCHP, and SERPINI2, which one shows the highest specificity for myeloid cells and represents the best candidate for targeting follicular lymphoma?","Among the genes MT-ND1, CHML, FAM219B, TCHP, and SERPINI2, which one shows the highest specificity for myeloid cells and represents the best candidate for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which myeloid cell–activated genes in PINNACLE overlap with these therapeutic targets to define a set of cell-type–specific targets for follicular lymphoma. Compute the average embedding for this set as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['TP53', 'CACTIN-AS1', 'CARTPT', 'VDAC1', 'FRMD4B']",follicular lymphoma,myeloid cell,TP53,"Among the candidate genes TP53, CACTIN-AS1, CARTPT, VDAC1, and FRMD4B, which exhibits the highest specificity for myeloid cells relevant to targeting follicular lymphoma?","Among the candidate genes TP53, CACTIN-AS1, CARTPT, VDAC1, and FRMD4B, which exhibits the highest specificity for myeloid cells relevant to targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which myeloid cell-activated genes in PINNACLE overlap with these targets to define the cell-type–specific target set for follicular lymphoma. Compute the average embedding for these genes and calculate the cosine similarity between this average and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GFRA4', 'OPN1MW', 'NDUFS8', 'RPS29', 'CPD']",follicular lymphoma,myeloid cell,NDUFS8,"Which gene—GFRA4, OPN1MW, NDUFS8, RPS29, or CPD—demonstrates the highest cell-type specificity in myeloid cells for targeting follicular lymphoma?","Which gene—GFRA4, OPN1MW, NDUFS8, RPS29, or CPD—demonstrates the highest cell-type specificity in myeloid cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Then, determine which myeloid cell-activated genes in PINNACLE intersect with these targets. For the overlapping genes, compute the average embedding as a reference and calculate the cosine similarity between this reference and each gene's embedding. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['E2F8', 'OSBP2', 'TYROBP', 'CELF2', 'TRIM7']",follicular lymphoma,myeloid cell,CELF2,"Which gene among E2F8, OSBP2, TYROBP, CELF2, and TRIM7 exhibits the highest cell-type-specific expression in myeloid cells, making it the best candidate for targeted treatment of follicular lymphoma?","Which gene among E2F8, OSBP2, TYROBP, CELF2, and TRIM7 exhibits the highest cell-type-specific expression in myeloid cells, making it the best candidate for targeted treatment of follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Determine which of these targets overlap with the myeloid cell-activated genes in the same dataset. For this overlapping set, calculate the average embedding to serve as a reference profile, then compute the cosine similarity between this reference and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a brief, evidence-based rationale for its biological relevance."
"['RPE65', 'UBE2E1', 'HIGD1A', 'LDHA', 'NDUFA5']",follicular lymphoma,myeloid cell,NDUFA5,"Among the genes RPE65, UBE2E1, HIGD1A, LDHA, and NDUFA5, which gene exhibits the highest specificity in myeloid cells for targeting follicular lymphoma?","Among the genes RPE65, UBE2E1, HIGD1A, LDHA, and NDUFA5, which gene exhibits the highest specificity in myeloid cells for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell type–specific embeddings from PINNACLE. Next, determine the intersection between these targets and myeloid cell–activated genes in PINNACLE, resulting in the cell type–specific targets for follicular lymphoma. Calculate the average embedding for this overlapping set and then compute the cosine similarity between this reference vector and each individual target embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['H1-5', 'SBSN', 'NDUFAF2', 'FCMR', 'PLA2G4A']",follicular lymphoma,myeloid cell,NDUFAF2,"Which of the following genes—H1-5', SBSN, NDUFAF2, FCMR, or PLA2G4A—exhibits the highest specificity for myeloid cells, making it the most promising target for follicular lymphoma therapy?","Which of the following genes—H1-5', SBSN, NDUFAF2, FCMR, or PLA2G4A—exhibits the highest specificity for myeloid cells, making it the most promising target for follicular lymphoma therapy? Identify the confirmed therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE database. Next, determine which of the myeloid cell–activated genes in PINNACLE overlap with these targets, defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set to serve as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['DEDD', 'FGR', 'RPS15', 'CLDN23', 'HERPUD1']",follicular lymphoma,myeloid cell,FGR,"Which gene among DEDD, FGR, RPS15, CLDN23, and HERPUD1 exhibits the highest cell-type specificity in myeloid cells, rendering it the best candidate for targeted intervention in follicular lymphoma?","Which gene among DEDD, FGR, RPS15, CLDN23, and HERPUD1 exhibits the highest cell-type specificity in myeloid cells, rendering it the best candidate for targeted intervention in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the myeloid cell-activated genes in PINNACLE to define the follicular lymphoma cell-type–specific targets. Calculate the average embedding for these targets and then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['EPAS1', 'CHST12', 'RBX1', 'RBM43', 'PFDN4']",follicular lymphoma,myeloid cell,RBX1,"Among EPAS1, CHST12, RBX1, RBM43, and PFDN4, which gene exhibits the highest specificity in myeloid cells, making it the optimal candidate for targeting follicular lymphoma?","Among EPAS1, CHST12, RBX1, RBM43, and PFDN4, which gene exhibits the highest specificity in myeloid cells, making it the optimal candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of the myeloid cell-activated genes in PINNACLE overlap with these therapeutic targets to define a set of cell-type–specific targets. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and each individual gene's embedding. If one gene displays a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['PAX8', 'HDAC10', 'LRP1', 'ZNF564', 'SUCLG1']",follicular lymphoma,myeloid cell,HDAC10,"Which gene among PAX8, HDAC10, LRP1, ZNF564, and SUCLG1 exhibits the highest cell-type specificity in myeloid cells, making it the most promising candidate for targeted therapy in follicular lymphoma?","Which gene among PAX8, HDAC10, LRP1, ZNF564, and SUCLG1 exhibits the highest cell-type specificity in myeloid cells, making it the most promising candidate for targeted therapy in follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and obtain their corresponding cell-type-specific embeddings from PINNACLE. Next, determine which myeloid cell-activated genes in PINNACLE overlap with these targets, yielding a set of cell-type-specific targets for the disease. Compute the average embedding of this set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['IREB2', 'ALB', 'TSPY2', 'USP6NL', 'RAB33B']",follicular lymphoma,myeloid cell,USP6NL,"Among the genes IREB2, ALB, TSPY2, USP6NL, and RAB33B, which one exhibits the highest myeloid cell-type specificity for follicular lymphoma targeting?","Among the genes IREB2, ALB, TSPY2, USP6NL, and RAB33B, which one exhibits the highest myeloid cell-type specificity for follicular lymphoma targeting? Identify the validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from the PINNACLE dataset. Next, determine the overlap between these targets and the genes activated in myeloid cells in PINNACLE. This overlapping set represents the cell-type–specific targets for follicular lymphoma. Calculate their average embedding to create a reference vector, then compute the cosine similarity between this reference and each individual target embedding. If one gene shows a significantly higher similarity than the others, nominate it as the lead candidate and provide a concise, evidence-based rationale for its relevance."
"['PASK', 'HSD17B7', 'CXCR4', 'VCP', 'PTPRN2']",follicular lymphoma,plasmacytoid dendritic cell,CXCR4,"Among the genes PASK, HSD17B7, CXCR4, VCP, and PTPRN2, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for therapeutic targeting of follicular lymphoma?","Among the genes PASK, HSD17B7, CXCR4, VCP, and PTPRN2, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for therapeutic targeting of follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell-activated genes in PINNACLE. For the overlapping set, calculate the average embedding as a reference, then compute the cosine similarity between this reference and each individual target. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based explanation of its biological relevance."
"['NDUFV1', 'CYP2F1', 'MAP3K13', 'NAA35', 'ADGRA3']",follicular lymphoma,plasmacytoid dendritic cell,NDUFV1,"Which gene among NDUFV1, CYP2F1, MAP3K13, NAA35, and ADGRA3 demonstrates the highest cell-type specific expression in plasmacytoid dendritic cells, making it the most promising candidate for targeting follicular lymphoma?","Which gene among NDUFV1, CYP2F1, MAP3K13, NAA35, and ADGRA3 demonstrates the highest cell-type specific expression in plasmacytoid dendritic cells, making it the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the plasmacytoid dendritic cell–activated genes in PINNACLE to define a set of cell-specific targets. Compute the average embedding for this set and then calculate the cosine similarity between this average and each individual target. If one gene exhibits significantly higher similarity than the others, designate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['API5', 'NUDT15', 'PIK3CG', 'SOWAHB', 'ZNF584']",follicular lymphoma,plasmacytoid dendritic cell,PIK3CG,"Which gene—API5, NUDT15, PIK3CG, SOWAHB, or ZNF584—exhibits the highest specificity to plasmacytoid dendritic cells in the context of targeting follicular lymphoma?","Which gene—API5, NUDT15, PIK3CG, SOWAHB, or ZNF584—exhibits the highest specificity to plasmacytoid dendritic cells in the context of targeting follicular lymphoma? Identify the established therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with plasmacytoid dendritic cell activation genes in PINNACLE. Compute the average embedding for this overlapping set and calculate the cosine similarity between the average embedding and each individual target. If one gene shows markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFS3', 'KLRF1', 'KRTAP15-1', 'GAA', 'NHLRC2']",follicular lymphoma,plasmacytoid dendritic cell,NDUFS3,"Which gene among NDUFS3, KLRF1, KRTAP15-1, GAA, and NHLRC2 exhibits the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma therapy?","Which gene among NDUFS3, KLRF1, KRTAP15-1, GAA, and NHLRC2 exhibits the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma therapy? Retrieve validated therapeutic targets for follicular lymphoma from PINNACLE along with their cell-type–specific embeddings. Next, identify which of these targets overlap with plasmacytoid dendritic cell-activated genes in PINNACLE to establish cell-type–specific targets. Compute the average embedding for this overlapping gene set as a reference, then calculate the cosine similarity between the reference and each individual target. If one gene shows significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['BTK', 'NYX', 'PHOX2B', 'GAGE13', 'CXorf51A']",follicular lymphoma,plasmacytoid dendritic cell,BTK,"Among BTK, NYX, PHOX2B, GAGE13, and CXorf51A, which gene exhibits the highest plasmacytoid dendritic cell specificity and could serve as the optimal target for follicular lymphoma therapy?","Among BTK, NYX, PHOX2B, GAGE13, and CXorf51A, which gene exhibits the highest plasmacytoid dendritic cell specificity and could serve as the optimal target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type-specific embeddings from the PINNACLE database. Then, determine which of the plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets to define the cell-type-specific target set for follicular lymphoma. Compute the average embedding for this set and calculate the cosine similarity between this average and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB11', 'CLK4', 'RAD51B', 'CALN1', 'SNAP47']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB11,"Among the genes NDUFB11, CLK4, RAD51B, CALN1, and SNAP47, which one shows the most specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes NDUFB11, CLK4, RAD51B, CALN1, and SNAP47, which one shows the most specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets associated with follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with plasmacytoid dendritic cell-activated genes in PINNACLE. Using this overlapping set as cell-type–specific targets for follicular lymphoma, compute the average embedding as a reference profile and calculate the cosine similarity between this reference and each individual target embedding. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['KRTAP5-3', 'ACSM2B', 'TUBB', 'BAHD1', 'DNAJB5']",follicular lymphoma,plasmacytoid dendritic cell,TUBB,"Among the candidate genes (KRTAP5-3', ACSM2B, TUBB, BAHD1, and DNAJB5), which one exhibits the most specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the candidate genes (KRTAP5-3', ACSM2B, TUBB, BAHD1, and DNAJB5), which one exhibits the most specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma? From the PINNACLE dataset, compile the validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings. Identify which of these targets overlap with plasmacytoid dendritic cell-activated genes to define a set of cell-type–specific targets for follicular lymphoma. Next, compute the average embedding for this overlapping set and then calculate the cosine similarity between this reference and the embedding of each individual target. If one gene shows a distinctly higher similarity than all others, nominate it as the prime candidate and provide a concise, evidence-based rationale for its biological significance."
"['TLR9', 'MTHFD2', 'SCMH1', 'CFAP161', 'RBKS']",follicular lymphoma,plasmacytoid dendritic cell,TLR9,"Among the genes TLR9, MTHFD2, SCMH1, CFAP161, and RBKS, which exhibits the highest cell-type specificity in plasmacytoid dendritic cells and should be prioritized as the candidate for targeted therapy against follicular lymphoma?","Among the genes TLR9, MTHFD2, SCMH1, CFAP161, and RBKS, which exhibits the highest cell-type specificity in plasmacytoid dendritic cells and should be prioritized as the candidate for targeted therapy against follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE database. Next, determine which plasmacytoid dendritic cell-activated genes in PINNACLE intersect with these targets. Compute the average embedding of this overlapping gene set as a reference and calculate the cosine similarity between this reference and each individual target's embedding. If one gene shows a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-supported explanation of its biological relevance."
"['MIB1', 'STRN4', 'KAT14', 'CDK4', 'PCTP']",follicular lymphoma,plasmacytoid dendritic cell,CDK4,"Which gene among MIB1, STRN4, KAT14, CDK4, and PCTP exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among MIB1, STRN4, KAT14, CDK4, and PCTP exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE dataset. Next, determine which of these targets overlap with the plasmacytoid dendritic cell-activated genes within PINNACLE to define a set of cell-type–specific targets. Calculate the average embedding of this overlapping set and then compute the cosine similarity between this average and the embeddings of each individual gene. If one gene demonstrates substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CAMK2D', 'LYN', 'FAM220A', 'CRB3', 'GOLGA8EP']",follicular lymphoma,plasmacytoid dendritic cell,LYN,"Which gene among CAMK2D, LYN, FAM220A, CRB3, and GOLGA8EP exhibits the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among CAMK2D, LYN, FAM220A, CRB3, and GOLGA8EP exhibits the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which of the plasmacytoid dendritic cell–activated genes in PINNACLE overlap with these targets. For this overlapping set, compute the average embedding to serve as a reference, and then calculate the cosine similarity between this reference and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, select it as the top candidate and provide a concise, evidence-based explanation of its biological relevance."
"['RASA4', 'ASIC2', 'MT-ND3', 'PRPF4', 'PCDHA2']",follicular lymphoma,plasmacytoid dendritic cell,MT-ND3,"Among the genes RASA4, ASIC2, MT-ND3, PRPF4, and PCDHA2, which one demonstrates the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Among the genes RASA4, ASIC2, MT-ND3, PRPF4, and PCDHA2, which one demonstrates the highest specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Using PINNACLE, retrieve the cell-type-specific embeddings for verified therapeutic targets in follicular lymphoma. Identify which plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets. For the overlapping subset, compute the average embedding and then calculate the cosine similarity between this reference and each individual gene’s embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance in follicular lymphoma."
"['ACADL', 'DPYSL2', 'NDUFB7', 'CHP1', 'MAPK14']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB7,"Which gene among ACADL, DPYSL2, NDUFB7, CHP1, and MAPK14 exhibits the highest expression specificity in plasmacytoid dendritic cells for targeted therapy in follicular lymphoma?","Which gene among ACADL, DPYSL2, NDUFB7, CHP1, and MAPK14 exhibits the highest expression specificity in plasmacytoid dendritic cells for targeted therapy in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets to obtain a refined set of cell-type–specific targets for the disease. Compute the average embedding of this overlapping set as a reference, then calculate the cosine similarity between this reference and each individual target gene. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a succinct, evidence-based rationale for its biological relevance."
"['DSC2', 'PTPRF', 'DCHS1', 'M6PR', 'NDUFA10']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA10,"Which gene among DSC2, PTPRF, DCHS1, M6PR, and NDUFA10 exhibits the highest specificity for plasmacytoid dendritic cells, thereby representing the most promising candidate for targeted follicular lymphoma therapy?","Which gene among DSC2, PTPRF, DCHS1, M6PR, and NDUFA10 exhibits the highest specificity for plasmacytoid dendritic cells, thereby representing the most promising candidate for targeted follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Determine the overlap between these targets and the plasmacytoid dendritic cell-activated genes retrieved from PINNACLE—this overlapping set represents the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this set as a reference and calculate the cosine similarity between each individual target and the reference. If one gene consistently shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['GPANK1', 'CCNI', 'MIS18A', 'TOP1', 'FOXRED2']",follicular lymphoma,plasmacytoid dendritic cell,TOP1,"Which gene among GPANK1, CCNI, MIS18A, TOP1, and FOXRED2 demonstrates the highest cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among GPANK1, CCNI, MIS18A, TOP1, and FOXRED2 demonstrates the highest cell-type-specific expression in plasmacytoid dendritic cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Which of these targets overlap with plasmacytoid dendritic cell-activated genes in PINNACLE? For the overlapping set, compute the average embedding and determine the cosine similarity between this reference and each individual target. If one gene shows a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFB5', 'RPL18A', 'KCNAB3', 'LSM14A', 'NEURL3']",follicular lymphoma,plasmacytoid dendritic cell,NDUFB5,"Which gene among NDUFB5, RPL18A, KCNAB3, LSM14A, and NEURL3 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma?","Which gene among NDUFB5, RPL18A, KCNAB3, LSM14A, and NEURL3 exhibits the highest cell-type specificity in plasmacytoid dendritic cells for targeting follicular lymphoma? Using the PINNACLE dataset, first identify the verified therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type-specific embeddings. Then, determine the overlap between these targets and the plasmacytoid dendritic cell–activated genes available in PINNACLE. For the overlapping subset, calculate the average embedding to serve as a reference, and compute the cosine similarity between this average and each individual target embedding. If one gene shows a distinctly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['CCL4L1', 'CC2D1A', 'MTHFD2L', 'AGPAT1', 'NDUFS4']",follicular lymphoma,plasmacytoid dendritic cell,NDUFS4,"Which gene among CCL4L1, CC2D1A, MTHFD2L, AGPAT1, and NDUFS4 exhibits the highest specificity for plasmacytoid dendritic cells, making it the most suitable candidate for targeting follicular lymphoma?","Which gene among CCL4L1, CC2D1A, MTHFD2L, AGPAT1, and NDUFS4 exhibits the highest specificity for plasmacytoid dendritic cells, making it the most suitable candidate for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and retrieve their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with plasmacytoid dendritic cell–activated genes listed in PINNACLE. For the overlapping genes, compute the average embedding and then calculate the cosine similarity between this average and each individual target embedding. If one gene exhibits a substantially higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['MAN1A2', 'NDUFA4', 'FANCL', 'KIF21A', 'CDK11B']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA4,"Which gene among MAN1A2, NDUFA4, FANCL, KIF21A, and CDK11B demonstrates the highest expression specificity in plasmacytoid dendritic cells, making it the most promising candidate for targeted follicular lymphoma therapy?","Which gene among MAN1A2, NDUFA4, FANCL, KIF21A, and CDK11B demonstrates the highest expression specificity in plasmacytoid dendritic cells, making it the most promising candidate for targeted follicular lymphoma therapy? Identify the set of verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine which plasmacytoid dendritic cell-activated genes in PINNACLE overlap with these targets. From this overlapping gene set, compute the average embedding as a reference, then calculate the cosine similarity between this reference and each individual gene embedding. If one gene exhibits a notably higher similarity relative to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance in follicular lymphoma."
"['PLSCR3', 'PCMTD2', 'CHP1P2', 'MRPS18A', 'NDUFA6']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA6,"Which gene among PLSCR3, PCMTD2, CHP1P2, MRPS18A, and NDUFA6 demonstrates the highest plasmacytoid dendritic cell-specific expression relevant to targeting follicular lymphoma?","Which gene among PLSCR3, PCMTD2, CHP1P2, MRPS18A, and NDUFA6 demonstrates the highest plasmacytoid dendritic cell-specific expression relevant to targeting follicular lymphoma? Using the verified therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from PINNACLE. Then, identify which targets overlap with the plasmacytoid dendritic cell–activated genes in PINNACLE to define the disease’s cell-type–specific targets. Compute the average embedding for these overlapping genes, and calculate the cosine similarity between this reference and each individual target. If one target shows a substantially higher similarity than the others, nominate it as the top candidate, and provide a brief, evidence-based explanation of its biological relevance."
"['GFPT2', 'NDUFS5', 'SLC25A17', 'SNIP1', 'GIP']",follicular lymphoma,plasmacytoid dendritic cell,NDUFS5,"Among the candidate genes GFPT2, NDUFS5, SLC25A17, SNIP1, and GIP, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma?","Among the candidate genes GFPT2, NDUFS5, SLC25A17, SNIP1, and GIP, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells, making it the most promising target for follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the plasmacytoid dendritic cell–activated genes in PINNACLE to define the cell-type-specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and each individual target's embedding. Finally, if one gene shows a significantly higher similarity score compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NAT1', 'NDUFA3', 'TNFSF9', 'DIO2', 'RRP12']",follicular lymphoma,plasmacytoid dendritic cell,NDUFA3,"Among the genes NAT1, NDUFA3, TNFSF9, DIO2, and RRP12, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for use as a targeted approach in follicular lymphoma?","Among the genes NAT1, NDUFA3, TNFSF9, DIO2, and RRP12, which one exhibits the highest cell-type specificity in plasmacytoid dendritic cells for use as a targeted approach in follicular lymphoma? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which plasmacytoid dendritic cell–activated gene embeddings overlap with these targets, thereby defining the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set and calculate the cosine similarity between this reference embedding and the embedding for each target gene. If one gene demonstrates markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['FGF8', 'PTDSS2', 'HDAC7', 'NDFIP1', 'MRPL15']",follicular lymphoma,b cell,HDAC7,"Among the genes FGF8, PTDSS2, HDAC7, NDFIP1, and MRPL15, which one exhibits the highest specificity for B cells for potential targeting in follicular lymphoma?","Among the genes FGF8, PTDSS2, HDAC7, NDFIP1, and MRPL15, which one exhibits the highest specificity for B cells for potential targeting in follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE database. Next, determine which b cell–activated genes in PINNACLE overlap with these targets. Calculate the average embedding of these overlapping genes as a reference and compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NUCB2', 'GATA2', 'FTCD', 'IFNAR2', 'SNX33']",follicular lymphoma,b cell,IFNAR2,"Among NUCB2, GATA2, FTCD, IFNAR2, and SNX33, which gene shows the highest B cell-specific expression, making it the most promising target for follicular lymphoma?","Among NUCB2, GATA2, FTCD, IFNAR2, and SNX33, which gene shows the highest B cell-specific expression, making it the most promising target for follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of b cell–activated genes from PINNACLE to define the cell-type–specific targets for follicular lymphoma. Compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['THOC5', 'HILPDA', 'NDUFA6', 'UGT1A9', 'ADCK5']",follicular lymphoma,b cell,NDUFA6,"Among THOC5, HILPDA, NDUFA6, UGT1A9, and ADCK5, which gene shows the highest B cell-specific expression and emerges as the most promising target for follicular lymphoma therapy?","Among THOC5, HILPDA, NDUFA6, UGT1A9, and ADCK5, which gene shows the highest B cell-specific expression and emerges as the most promising target for follicular lymphoma therapy? Identify validated therapeutic targets for follicular lymphoma and extract their corresponding cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the B cell-activated gene set in PINNACLE. For the overlapping genes, compute their average embedding to create a reference vector, then calculate the cosine similarity between this reference and each individual target’s embedding. If one gene displays a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BCL2L1', 'UBC', 'PPP2R5A', 'DPP8', 'SUGT1']",follicular lymphoma,b cell,BCL2L1,"Among the genes BCL2L1, UBC, PPP2R5A, DPP8, and SUGT1, which one exhibits the most B cell–specific expression, making it the prime candidate for targeted therapy in follicular lymphoma?","Among the genes BCL2L1, UBC, PPP2R5A, DPP8, and SUGT1, which one exhibits the most B cell–specific expression, making it the prime candidate for targeted therapy in follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell type–specific embeddings from PINNACLE. Next, determine which B cell–activated genes in PINNACLE overlap with these targets to define the cell type–specific targets for follicular lymphoma. Compute the average embedding of these overlapping genes and calculate the cosine similarity between this average and each individual target. If one gene shows a substantially higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['PRIM1', 'CIDEC', 'KIF23', 'ABTB1', 'DPH1']",follicular lymphoma,b cell,PRIM1,"Which gene among PRIM1, CIDEC, KIF23, ABTB1, and DPH1 exhibits the highest specificity for B cells in the context of follicular lymphoma?","Which gene among PRIM1, CIDEC, KIF23, ABTB1, and DPH1 exhibits the highest specificity for B cells in the context of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from the PINNACLE database. Next, determine the intersection between these targets and the set of B cell-activated genes in PINNACLE. For the overlapping genes, compute their average embedding and then calculate the cosine similarity between this reference and each individual gene embedding. If one gene stands out with a significantly higher similarity score, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['OLFM1', 'EDEM2', 'GRAMD1A', 'SCRN1', 'CELF2']",follicular lymphoma,b cell,CELF2,"Which gene among OLFM1, EDEM2, GRAMD1A, SCRN1, and CELF2 exhibits the highest specificity in B cells for targeting follicular lymphoma?","Which gene among OLFM1, EDEM2, GRAMD1A, SCRN1, and CELF2 exhibits the highest specificity in B cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from the PINNACLE database. Next, determine which of these targets overlap with B cell–activated genes in the same database to define a specific set of targets for follicular lymphoma. Compute the average embedding of this overlapping set and then calculate the cosine similarity between this average and each individual target's embedding. If one gene demonstrates a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['ERCC6L2', 'SPIRE1', 'FYN', 'ENTPD1', 'PROCA1']",follicular lymphoma,b cell,FYN,"Among ERCC6L2, SPIRE1, FYN, ENTPD1, and PROCA1, which gene exhibits the highest specificity in B cells for targeting follicular lymphoma?","Among ERCC6L2, SPIRE1, FYN, ENTPD1, and PROCA1, which gene exhibits the highest specificity in B cells for targeting follicular lymphoma? Identify the verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which target genes overlap with the B cell-activated gene set in PINNACLE and compute the average embedding for this overlapping set. Finally, calculate the cosine similarity between this average embedding and each individual candidate. If one gene exhibits significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['RRM1', 'ZC3H12C', 'GALNT8', 'FOXRED2', 'HSPB6']",follicular lymphoma,b cell,RRM1,"Among the genes RRM1, ZC3H12C, GALNT8, FOXRED2, and HSPB6, which one exhibits the highest B cell-specific expression for potential targeting of follicular lymphoma?","Among the genes RRM1, ZC3H12C, GALNT8, FOXRED2, and HSPB6, which one exhibits the highest B cell-specific expression for potential targeting of follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the set of B cell–activated genes in PINNACLE; this overlap defines the cell-type–specific targets for follicular lymphoma. Compute the average embedding for this overlapping set, then calculate the cosine similarity between this average and the embedding of each individual target. If one gene demonstrates significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HDAC3', 'RFT1', 'C10orf55', 'HSD17B12', 'TBC1D32']",follicular lymphoma,b cell,HDAC3,"Which gene among HDAC3, RFT1, C10orf55, HSD17B12, and TBC1D32 exhibits the highest specificity in B cells for targeting follicular lymphoma?","Which gene among HDAC3, RFT1, C10orf55, HSD17B12, and TBC1D32 exhibits the highest specificity in B cells for targeting follicular lymphoma? Identify validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Determine which of these targets overlap with the set of B cell–activated genes in PINNACLE. Compute the average embedding for this overlapping group and calculate the cosine similarity between this reference and each individual target. If a single gene exhibits a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['UGT1A10', 'PTGS1', 'MEPE', 'BTBD1', 'OSM']",follicular lymphoma,b cell,PTGS1,"Among the following genes—UGT1A10, PTGS1, MEPE, BTBD1, and OSM—which shows the highest specificity in B cells, making it the most promising target for follicular lymphoma therapy?","Among the following genes—UGT1A10, PTGS1, MEPE, BTBD1, and OSM—which shows the highest specificity in B cells, making it the most promising target for follicular lymphoma therapy? Identify the verified therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from PINNACLE. Next, determine the overlap between these targets and the b cell-activated genes in PINNACLE to obtain the set of follicular lymphoma cell-type–specific targets. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between the average embedding and each individual target. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['ZNF415', 'POLR2H', 'HDGFL3', 'NDUFA13', 'KHDRBS3']",follicular lymphoma,b cell,NDUFA13,"Which gene among ZNF415, POLR2H, HDGFL3, NDUFA13, and KHDRBS3 exhibits the highest B cell specificity for targeting follicular lymphoma?","Which gene among ZNF415, POLR2H, HDGFL3, NDUFA13, and KHDRBS3 exhibits the highest B cell specificity for targeting follicular lymphoma? Identify therapeutic targets for follicular lymphoma by extracting their cell-type-specific embeddings from PINNACLE. Next, determine the intersection of these targets with genes activated in B cells, and compute the average embedding of this overlapping set as a reference. Calculate the cosine similarity between each gene’s embedding and the reference, and if one gene shows a clearly higher similarity than the others, nominate it as the leading candidate. Provide a concise, evidence-based justification for its biological relevance in follicular lymphoma."
"['CARNMT1', 'EPB41L5', 'ZNF205-AS1', 'PDCD1', 'VPS18']",follicular lymphoma,b cell,PDCD1,"Among the candidate genes (CARNMT1, EPB41L5, ZNF205-AS1, PDCD1, and VPS18), which one exhibits the highest B cell specificity for targeting follicular lymphoma?","Among the candidate genes (CARNMT1, EPB41L5, ZNF205-AS1, PDCD1, and VPS18), which one exhibits the highest B cell specificity for targeting follicular lymphoma? Retrieve the validated therapeutic targets for follicular lymphoma and obtain their cell-type–specific embeddings from the PINNACLE dataset. Identify the subset of these targets that overlaps with B cell–activated genes in PINNACLE, thereby defining the cell-type–specific target set for follicular lymphoma. Compute the average embedding for this overlapping set, and then calculate the cosine similarity between this reference embedding and each individual gene embedding within the set. If one gene exhibits significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['BOLA1', 'EFHD2', 'HLA-DRB1', 'KIR3DS1', 'SRFBP1']",follicular lymphoma,b cell,HLA-DRB1,"Among the genes BOLA1, EFHD2, HLA-DRB1, KIR3DS1, and SRFBP1, which one exhibits the highest specificity for B cells in the context of targeting follicular lymphoma?","Among the genes BOLA1, EFHD2, HLA-DRB1, KIR3DS1, and SRFBP1, which one exhibits the highest specificity for B cells in the context of targeting follicular lymphoma? Identify the confirmed therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from the PINNACLE dataset. Next, identify the subset of B cell–activated genes within PINNACLE that overlap with these targets, and calculate their average embedding. Then, compute the cosine similarity between this average embedding and each individual overlapping gene's embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate, and provide a concise, evidence-based rationale for its biological relevance."
"['OAZ1', 'COLEC12', 'NDUFA3', 'RELA', 'CSE1L']",follicular lymphoma,b cell,NDUFA3,"Among the genes OAZ1, COLEC12, NDUFA3, RELA, and CSE1L, which one exhibits the highest B cell-specific expression and would be the most promising target for follicular lymphoma therapy?","Among the genes OAZ1, COLEC12, NDUFA3, RELA, and CSE1L, which one exhibits the highest B cell-specific expression and would be the most promising target for follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma and obtain their cell type–specific embeddings from PINNACLE. Next, determine which of the B cell–activated genes in PINNACLE overlap with these targets to define the cell type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set and compute the cosine similarity between this reference and each individual target. If one gene exhibits a significantly higher similarity compared to the others, nominate it as the top candidate and provide a concise, evidence-based justification for its biological significance."
"['TLR9', 'FNIP2', 'MYOC', 'TTPAL', 'PPP5C']",follicular lymphoma,b cell,TLR9,"Among the genes TLR9, FNIP2, MYOC, TTPAL, and PPP5C, which shows the highest B cell-specific expression and is therefore the most promising candidate for targeting follicular lymphoma?","Among the genes TLR9, FNIP2, MYOC, TTPAL, and PPP5C, which shows the highest B cell-specific expression and is therefore the most promising candidate for targeting follicular lymphoma? Identify the validated therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, define the subset of these targets that overlap with the set of B cell–activated genes in PINNACLE, establishing them as cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this subset to serve as a reference vector, and then compute the cosine similarity between each individual target embedding and this reference. If one gene consistently exhibits a markedly higher similarity, nominate it as the top candidate and provide a concise, evidence-based explanation for its biological relevance."
"['ITCH', 'PIK3C2B', 'CEP192', 'NDUFS5', 'NBPF19']",follicular lymphoma,b cell,NDUFS5,"Among the genes ITCH, PIK3C2B, CEP192, NDUFS5, and NBPF19, which demonstrates the highest specificity of expression in B cells while serving as a potential target for follicular lymphoma therapy?","Among the genes ITCH, PIK3C2B, CEP192, NDUFS5, and NBPF19, which demonstrates the highest specificity of expression in B cells while serving as a potential target for follicular lymphoma therapy? Identify verified therapeutic targets for follicular lymphoma and extract their cell-type–specific embeddings from PINNACLE. Next, determine which of the B cell activation-related genes in PINNACLE overlap with these targets, thus defining the cell-type–specific targets for follicular lymphoma. Calculate the average embedding of this overlapping set as a reference, then compute the cosine similarity between this reference and each individual target embedding. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['HOMER2', 'MTX2', 'TRMT6', 'SYK', 'SLC7A6OS']",follicular lymphoma,b cell,SYK,"Which gene among HOMER2, MTX2, TRMT6, SYK, and SLC7A6OS exhibits the most pronounced B cell-specific expression, thereby representing the best candidate for targeted follicular lymphoma treatment?","Which gene among HOMER2, MTX2, TRMT6, SYK, and SLC7A6OS exhibits the most pronounced B cell-specific expression, thereby representing the best candidate for targeted follicular lymphoma treatment? Identify validated therapeutic targets for follicular lymphoma and retrieve their cell-type–specific embeddings from PINNACLE. Next, determine which of these targets overlap with the B cell activation gene embeddings in PINNACLE. Calculate the average embedding of this overlapping gene set and then compute the cosine similarity between this average and each individual target embedding. If one gene shows considerably higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFC1', 'PGAM2', 'USP40', 'GHRL', 'DCP1A']",follicular lymphoma,b cell,NDUFC1,"Which gene among NDUFC1, PGAM2, USP40, GHRL, and DCP1A exhibits the greatest cell-type specificity for B cells, thereby representing the most suitable candidate for targeted follicular lymphoma therapy?","Which gene among NDUFC1, PGAM2, USP40, GHRL, and DCP1A exhibits the greatest cell-type specificity for B cells, thereby representing the most suitable candidate for targeted follicular lymphoma therapy? Identify the validated therapeutic targets for follicular lymphoma from PINNACLE and retrieve their cell-type–specific embeddings. Next, determine which B cell–activated genes in PINNACLE overlap with these targets. For the overlapping set, compute the average embedding and then calculate the cosine similarity between this average and each individual target’s embedding. If one gene exhibits a markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological significance."
"['HSP90AA1', 'CTBP2', 'SRPRA', 'PVR', 'LRRN1']",follicular lymphoma,b cell,HSP90AA1,"Among the genes HSP90AA1, CTBP2, SRPRA, PVR, and LRRN1, which exhibits the highest specificity for B cells in the context of follicular lymphoma targeting?","Among the genes HSP90AA1, CTBP2, SRPRA, PVR, and LRRN1, which exhibits the highest specificity for B cells in the context of follicular lymphoma targeting? Identify the validated therapeutic targets for follicular lymphoma and retrieve their cell-type-specific embeddings from PINNACLE. Next, determine the overlap between these targets and the B cell-activated genes defined by PINNACLE. Use this overlapping set as the follicular lymphoma cell-type-specific targets, compute their average embedding as a reference, and calculate the cosine similarity between this reference and each individual target. If one gene exhibits markedly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
"['NDUFV3', 'SRCAP', 'FOXS1', 'SORT1', 'ASB7']",follicular lymphoma,b cell,NDUFV3,"Which gene among NDUFV3, SRCAP, FOXS1, SORT1, and ASB7 shows the highest specificity for B cells, making it the most promising molecular target for follicular lymphoma?","Which gene among NDUFV3, SRCAP, FOXS1, SORT1, and ASB7 shows the highest specificity for B cells, making it the most promising molecular target for follicular lymphoma? Given the verified therapeutic targets for follicular lymphoma, retrieve their cell-type–specific embeddings from PINNACLE. Identify which b cell–activated genes in PINNACLE overlap with these targets to define the cell-type–specific targets for follicular lymphoma. Then, compute the average embedding of this overlapping set and calculate the cosine similarity between this average and each individual target's embedding. If one gene exhibits a significantly higher similarity than the others, nominate it as the top candidate and provide a concise, evidence-based rationale for its biological relevance."
